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welcome to Fusion
Dear George Washington Medical Community, Faculty, and Students:

FUSION EDITORS:

From left: Eric Signoff, MSII;
Kristen Batich, MSII; Thomas
Zaikos, MSI; Stephen Swank,
MSII; Jana Freeman, MSII;
and Gena Gora, MSII.

Welcome to the 2011 edition of Fusion, a completely student-run research journal by The
George Washington University’s William H.
Beaumont Medical Research Honor Society at
GW’s School of Medicine and Health Science
(SMHS). Beaumont aims to promote the value
of research for students in the medical community. Among our activities, including journal
clubs and Research Day, the most rewarding
aspect of this society is working with our
classmates and future colleagues to publish this
journal.
Fusion is aptly named: the journal embodies
the link between science and medicine, as
articles span the gamut of scientific disciplines
and clinical subspecialties both domestic and
abroad. In medicine, hard science and bench
research yield clinical trials, which in turn
guide bedside practices and public health campaigns. Our journal features student research
and perspectives in all of these phases, which
is in part what makes medicine such a collaborative and exciting field. As busy medical
students, it often becomes easy to approach
our studies as a block of knowledge to memorize; but when we engage in research projects
and discussions with classmates, we find that

the process of learning can and should be a
dynamic one. This is what Fusion is all about
— student interest in research — the very
thing that moves medicine forward.
The theme of GW Research Day and this
magazine is advancing cancer research. Our
cover image was created by Kenneth Morford,
MSII. Through a multimedia piece, Morford’s
depiction represents the importance of interdisciplinary collaboration in medical research and
highlights the art of medicine.
Finally, we would like to take this opportunity to acknowledge and thank our new faculty
advisor, Vincent A. Chiappinelli, PhD, interim
associate vice provost for Health Affairs, and
associate dean of SMHS. His guidance and
enthusiasm throughout the year has provided
us with inspiration and a sense of purpose.
We are very proud of this edition of Fusion
and the hard work that our colleagues put forth
into creating this magazine. It is our hope that
you will find as much enjoyment and inspiration flipping through the following pages as we
did editing them.
Your editors,
Eric, Gena, Jana, Kristen, Stephen, and Thomas
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from the dean’s office
The Practice of Medicine: A Balance Between Art and Science

Vincent A. Chiappinelli, PhD
Interim Associate Vice
Provost for Health
Affairs, Associate Dean
of the School of Medicine
and Health Sciences,
and Ralph E. Loewy
Professor and Chair
of Pharmacology and
Physiology

It has been a pleasure to serve as the faculty advisor to the William H. Beaumont
Medical Research Honor Society. The Beaumont Society is a student-run organization
that brings together students with a very wide range of research interests and
experiences, from basic biomedical research to clinical studies to health policy research.
Fusion is the showcase for these students’ work, and this year’s edition is a fascinating
window into their research world.
Medicine is both art and science, and gaining experience in both of these aspects
of the field is rewarding and can lead in unexpected directions. I recommend going
with what you find most interesting. An early interest in the development of the
nervous system triggered my studies of nicotinic acetylcholine receptors. Finding a
lack of drugs that could be used as probes for these neuronal receptors, I began to
isolate proteins from snake venom and test their potencies as antagonists at these
receptors. This led to the discovery of kappa-bungarotoxin. To gain more insight into
how this toxin blocked nicotinic receptors I travelled to parts of China and Taiwan
where these poisonous snakes live, and working with my collaborators I was able to
purify additional kappa-neurotoxins. You never know where your research will take
you, but it is challenging, often fun, and surprisingly social as interactions with other
scientists are essential in cutting-edge research.
Medical students have a long tradition as biomedical researchers. It was a medical
student who in 1846 first publicly demonstrated the remarkable value of ether as a
general anesthetic. The research experiences of our GW medical students described
in Fusion are the result of hard work, major successes and minor disasters, and above
all a dedication to push the window so that science can inform decision making for
both medical doctors and our society. The faculty members of SMHS congratulate
the students of the Beaumont Society and express our warmest wishes for your future
journeys through art and science.

Fusion is a publication of
The George Washington University School
of Medicine and Health Sciences
William H. Beaumont
Medical Research Honor Society.
This research journal is published
by students in collaboration with
the Office of the Dean and the Medical Center
Office of Communications and Marketing.
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advice from an expert
The Researcher’s Art is First of All to Find Himself a Good Boss.
This issue of Fusion is a celebration of the vibrant research community that flourishes
at The George Washington University. In any medical student’s busy life it can be hard
to find the time to do anything other than study and absorb pages of information;
but the number of students who have not only found time to become involved with
research, but also have had the patience and fortitude to see their projects through
to the stage of presentation is quite remarkable. Now, where do you go from here?
For some of you it will be enough to have participated in your project and you may
have decided, upon reflection, that research is not going to be your final career choice.
For others, this opportunity may have resulted in the opposite conclusion. But whether
you focus on clinical practice or research, your success will likely depend on following
André Lwoff’s advice: find yourself a good boss. Lwoff was a French physician and
microbiologist and was awarded the Nobel Prize in Medicine in 1965 for his discovery
that some viruses infect bacteria. Lwoff also knew a thing or two about finding a good
boss — or in the language that we use today — a good mentor; early in his career he
spent a spent a year working for Otto Meyerhof — also a Nobel Prize winner — in
Heidelberg. Having spent at least four years being mentored (and sometimes perhaps
bossed, too) you will have seen many different styles of both teaching and treating.
Your greatest ticket to success is to emulate the very best practices that you have seen
and consciously shun those that you observed to be counter productive. Did your
mentor use a line with a patient that seemed to work well? If so, use it yourself. And
if you saw an empathetic physician reach out to a patient, copy that technique and
pass it on. When it comes to research this advice is just as important. To be a great
researcher you need a boss who can be a role model — someone you can both emulate and to whom you can reach out. This goal is of course a lofty one; mentors and
leaders after all are only human, and they may have great skills in one area but be
utterly wanting in others. That is why I suggest amending Lwoff’s advice. Don’t find
one good boss or mentor, but rather several, and take the very best traits from each.
Many years ago, while a medical student in London, I read a long piece in the
London Times by a distinguished Professor of Medical Ethics that outlined the reasons
why research on human embryos should be banned. Rather naïvely, I wrote an equally
long piece on what I considered to be the flaws in the argument, and discussed it with
a mentor of mine who not only showed me the problems with my own reasoning, but
encouraged me to publish the piece. Thanks to his mentorship I did precisely that. It
was not perhaps a Nobel Prize winning publication, but the mentorship and advice
was worth a lot more than the two lines the article took up on my resume, because
it showed me how it was possible to become involved even as a young student, in the
conversation and research that shapes the society in which we live. As young physicians and researchers you will have an important role in shaping the society in which
you choose to make your homes. So choose your next boss wisely, for whether you
will become a Nobel Prize winner or an excellent and compassionate physician, your
boss — or bosses — will have a key role to play.

Jeremy Brown, MD,
associate professor of
Emergency Medicine, GW
School of Medicine and
Health Sciences

Cited in Max Perutz, Is science necessary? Essays on Science and scientists, (1991), 194.
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perspectives
Earth’s Chief Complaint: Climate Change
As global climate
change continues
to i mp a c t t he
environment in
which we live,
hu m a n he a lt h
is a nd w i l l be
deeply affected.
Rachel Harold, MSII
Direc t hea lt h
Advisor: John Balbus, MD,
impacts may take
MPH, National Institute
numerous forms:
of Environmental Health
increased extreme
Sciences
heat events like
the one that killed
approximately 30,000, mostly elderly,
people in Europe in 2003;1 expanding
geographic and seasonal ranges of vectorborne diseases such as Dengue; increased
frequency of severe weather events such
as hurricanes; and respiratory illnesses
such as asthma due to changes in air
quality. In addition, there will be health
implications that result indirectly from
climate change such as the morbidity
and mortality associated with food and

by reducing greenhouse gas emissions,
shifting the paradigm away from preventative policy change and focusing efforts
on adaptation strategies to help global
citizens handle the expected impacts of
climate change. From
While the issue of climate change may a health perspective,
inaction on climate
appear static in the halls of Congress and the change is especially
imprudent because
summits in Copenhagen and Cancun, it is there are many positive
certainly moving into our exam rooms and health outcomes associated with reducing
hospitals. Clinics across the world will soon g reen hou se g a se s.
These “co-benefits”
be full of patients with a chief complaint of (and occasional “coharms”) are expected
climate change.
to result from changes
that our global society
makes to respond to climate change. For
water insecurity resulting from droughts
example, if communities increase public
and floods. Climate change is expected
transportation infrastructure and create
to take many of the health issues we
more systems for walking and biking
already can’t control and increase their
in their built communities to reduce
frequency, their reach, and their severity.2
greenhouse gas emissions from cars, then
Unfortunately, many global leaders
the incidence of health problems such as
have been hesitant to take bold steps to
obesity and cardiovascular disease will
mitigate the impacts of climate change
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Art by Kenneth Morford, MSII

be reduced due to increased exercise.
Another example includes replacing
pervasive dirty biomass-burning indoor
cook-stoves in countries such as India
with low emission cook-stoves. Climatealtering emissions would be reduced, but
so too would cases of chronic obstructive
pulmonary disease, acute lower respiratory infections in children, and ischemic
heart disease that are exacerbated and
sometimes caused by indoor air pollution. In November 2009, the Lancet
released a series that quantitatively modeled these and other predicted public
health outcomes of specific strategies
to reduce climate change. The results
suggested significant short-term health
benefits while reducing future health,
economic, and ecosystem risks.
While political leaders may be
responding slowly to the climate issue,
the scientific and health communities
are working hard to manage and prevent
widespread health disasters. For example,
the Group on Earth Observations is
using satellite technology to monitor
drought conditions in sub-Sahara Africa
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which often precede major meningitis
outbreaks. Meanwhile, the National
Institutes of Health and the Centers
for Disease Control and Prevention are
working to create a cohesive national
research agenda and help individual
communities prepare for the health challenges of climate change, some of which
may be new to American soil.
While the issue of climate change
may appear static in the halls of Congress
and the summits in Copenhagen and
Cancun, it is certainly moving into our
exam rooms and hospitals. Clinics across

the world will soon be full of patients
with a chief complaint of climate change.

3.

HAINES A, MCMICHAEL AJ, SMITH KR, ET AL. (2009).
Public health benefits of strategies to reduce
greenhouse-gas emissions: over view and
implications for policy makers. Lancet; 374:
2104–2114

4.

GROUP ON EARTH OBSERVATIONS. (2008). 2009–10
GEO Health Tasks. [Brochure]. Prepared by
the United States Environmental Protection
Agency.

5.

NATIONAL INSTITUTES OF ENVIRONMENTAL HEALTH
SCIENCES, NATIONAL INSTITUTES OF HEALTH. (2010).
NIH-led Interagency Group Identifies Research
Needs to Study Climate Change and Human
Health Impacts [Press release]. Retrieved from
www.niehs.nih.gov/news/releases/2010/nih-led.
cfm Pontiac_GCPOY.htm.

REFERENCES:
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of Summer 2003 Heat Wave in Europe.
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Human Health Perspective on Climate Change:
a Report Outlining the Research Needs on the
Human Health Effects of Climate Change.
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To Tell or Not to Tell: On Disclosing the Diagnosis of Dementia
As the number of
older persons (age
65 and older) in
the United States
continues to
rapidly rise, particularly with the
Ay h a n Yo r u k , M S I
imminent aging
Advisor: Victoria H.
of the baby boom
Raveis, PhD, Mailman
generation, there
School of Public Health,
will be a signifiColumbia University
cant increase in
the incidence of
age-related Alzheimer’s disease. An
incurable, degenerative, and terminal
disease, Alzheimer’s currently inflicts
more than 35 million individuals worldwide and its prevalence is projected to
reach approximately 107 million by
the year 2050.1 Given the major impact
of the diagnosis of Alzheimer’s disease
on not only the patients, but also their
family and caregivers, the medical practitioners’ attitudes and practices regarding
the disclosure of diagnosis, as related to
the field of dementia, is of great concern.
Should physicians communicate a
diagnosis of Alzheimer’s disease to their
patients? Physicians show great variation
in practice, with fewer than half of clinicians regularly reporting a diagnosis of
Alzheimer’s to their patients.2 Weighing
the effect of the decision on patients,
families, physicians, and the larger health
care system as we evaluate the reasons
for telling or not telling, this brief will

PERSPECTIVES

outline the importance of straightforward communication.
The arguments that have typically
been put forth against diagnostic disclosure are based largely on the principle of
non-maleficence, which is the obligation
to avoid harm. The emphasis on avoiding
harm to patients has relied on (1) the
lack of absolute diagnostic certainty
without post-mortem clinical information, (2) the fact that treatment options
are limited, and there is no cure, (3) the
questionable ability of patients, particularly those in advanced stages of the
disease, to understand the implications
of the diagnosis, and (4) the potential for
adverse, or even catastrophic, psychological responses to diagnostic disclosure
as their justification.3
The arguments that have typically been put forth in support of diagnostic disclosure are
based largely on the principle
of providing the care that the
patient deserves (justice) and patient
autonomy. “Positive reasons for
disclosure range from ‘the patient’s
right to know’ and facilitation of
future planning to ‘taking that
once in a lifetime holiday.’ ”2
Of particular importance is
the framework within which
target symptoms and symptomatic treatment options can be
discussed3 as well as opportunities to learn of and engage

in therapeutic and clinical trials.5
It is my view that all medical professionals should adopt the practice of
absolute truth-telling. There are many
rational reasons for non-disclosure, but
there is a lack of evidence supporting that
it is more beneficial than truth-telling.
Many believe that the negative outcomes
anticipated by physicians and caregivers
alike are worse than that evidenced in
reality. In fact, literature supporting
the diagnostic disclosure of Alzheimer’s
disease is increasing.

DEMENTIA

Continued on p. 6
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DEMENTIA

Continued from p. 5

A campaign to convince medical
practitioners of the benefits of disclosing
the diagnosis of dementia, particularly
when compared to the disadvantages,
may prove highly successful in promoting
the absolute disclosure of diagnoses. This
may be accomplished through advocacy
via medical professional organizations
or even publishing studies weighing the
pros and cons of disclosing the diagnosis
of dementia. Moreover, a campaign to
train medical professionals on when
and how to tell their patients may prove
beneficial, as well as breaking common
misconceptions and fears of disclosing

the diagnoses. The failure to diagnose
and treat persons with Alzheimer’s
disease is commonly attributed to the
lack of physicians’ knowledge about
dementing illnesses, the absence of
cognitive screening and the public
perception that nothing can be done
about the disease.6 Further research and
advancements in fields exploring the
aforementioned limitations is highly
recommended, particularly as our society
readies itself for the rapidly growing
aging-population.

REFERENCES:
1.
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Sherley Pétion: A Resilient Spirit in the Midst of the Devastation in Haiti
Her na me wa s
Sherley Pétion.
A native of Portau-Prince, Haiti,
she was a nurse
working with me
for the summer.
The first time we
Jeffanne Millein, MSII
met, she was in
Advisor: Melissa Curtice,
her white scrubs,
RN, BSN, MSN, CNM,
carefully feeding a
Truman Medical Center
premature infant
from a dropper.
She barely looked up as I introduced
myself, so absorbed in her work that
an introduction was really a minimal
priority. One afternoon, with all work
done for the day, we remained in the
delivery room waiting for labor or emergency cases. She sat in her usual seat, a
white chair, near the door-less dressing
room. We were talking about mundane
things when she revealed how she had
lost everything during the earthquake.
A month prior, she was planning her
wedding to the “perfect guy.” She paused
briefly as the painful memory overtook
her. The soft lines under her eyes creased
and the scar near her left eye seemed to
cringe at the next few words. “He died
suddenly a month before the earthquake.
Just like that,” she said softly. Then a
couple of weeks later the earthquake
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hit and completely destroyed her home.
She fled from the capitol and moved in
with her cousin who lived in St. Louis
du Nord, in northwest Haiti. Sherley
described how she was despondent and
barely able to function. Yet despite it
all, she gradually found pieces of herself
in her work. The premature infant she
was caring for was able to go home, a
healthy and growing little boy—all due
to the time and compassion that Sherley
showed in caring for him.
This clinic in St. Louis du Nord
was a mere eight miles from where I
grew up. My research focused on preeclampsia and eclampsia care in a rural
setting, surveying the different stresses
in patients’ lives, how often they accessed
care during their term and difficulties
encountered getting to the clinic. We
discovered that many of the women
travelled long distances at early hours
to secure doctor appointments. Many
patients were young and barely educated.
Most women lacked the financial means
to properly take care of themselves and
hence had underlying problems with
their pregnancies. Even with diet
recommendations and proper sex
education, patient compliance
remained low due to lack of
resources. However, for many
of the women who come, they

receive quality care for most of their ailments and usually give birth to healthy
babies.
I initially thought that I would go
to Haiti having something to offer. But
it was my interactions with the people I
met and the relationships we built that
contributed the most to my learning
experience. Their resilience and refusal
to stop living despite their difficult lives
have muted my protests with struggles
encountered in medical school and
beyond. From Sherley’s story to the
mother who still has trouble recovering
from losing a child a year ago, I have
found a broader sense of purpose in my
aspirations of becoming a physician.
Their courage
has inspired
me to be
better.

Sherley Pétion and her young patient
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basic science
Brain Structural Evidence of Epistasis Between RGS4 and COMT
Variations in Schizophrenia
Schizophrenia is
a debilitating psychiatric disorder
with a worldwide
preva lence of
1%. Clinically,
schizophrenia is
characterized by
M a r c L e n e r, M S I V
Advisor: Konasale Prasad,
thought disorder,
MD, University of Pittslack of emotional
burgh School of Medicine
responsiveness,
auditory hallucinations, and paranoid delusions. With
heritability calculated at 81%, genetic
association studies have identified several susceptibility loci and numerous
genes linked to schizophrenia.3,6 Among
the most significant candidate risk
genes for schizophrenia, polymorphisms of the Catechol-O-methyl transferase (COMT) and the Regulator of
G-protein Signaling 4 (RGS4) demonstrate great potential to act interactively
in schizophrenic patients.1,4,5
The membrane-associated isotype
of COMT is responsible for catalyzing
the inactivation of dopamine and is
found mainly in the prefrontal cortex
and hippocampus. RGS4 is a GTPase
activator that acts to inhibit Gi/o and
Gq, resulting in the attenuation of dopaminergic signal transduction at specific
dopamine receptors. Interestingly, a
reciprocal interaction occurs such that
RGS4 gene expression is regulated by
the increased activation of the GPCRs
it modulates. Based on previously found
interactions between both RGS4 and
COMT2,6,7 studies investigating functional epistasis of RGS4 and COMT
in schizophrenic patients showed prefrontal cortical and hippocampal dysregulation in association with abnormal
dopamine signaling1 consistent with a
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FIGURE: Glass brain pictures and rendering on to T1 image. Shaded Areas- voxels demonstrating RGS4 and COMT
interaction via grey matter volumetric reduction with significance of p < 0.01. Blue Areas - significant voxels at p < 0.001.

dopamine hypothesis for schizophrenia.
In our study, we evaluated our samples
for similar associations and, in addition,
examined epistatic interactions of RGS4
polymorphisms on grey matter volumes
among patients and healthy subjects.
We examined structural MRI scans
from 21 ﬁrst-episode, antipsychoticnaïve schizophrenia or schizoaffective
disorder subjects and 19 healthy subjects using tests for interaction using
voxel-based morphometry to examine
grey matter alterations associated with
COMT and RGS4 risk alleles both
independently and interactively. We
observed RGS4 and COMT interactions in the posterior cingulate, insular,
occipital, and temporal regions. The
most consistent finding among all
interactions was grey matter reductions

at the inferior and superior temporal
gyri, corresponding to the heteromodal
association areas (See Figure).
Our observations suggest that RGS4
and COMT variations are independently
and epistatically associated with grey
matter reductions at the dorsal components of heteromodal association areas,
a collection of interconnected network
of neural circuits that may be affected by
genetically determined neurodevelopmental abnormalities in schizophrenic
patients. Previous associations of functional interaction between COMT and
RGS4 with altered working memory
performance and Blood Oxygen-Level
Dependence (BOLD) responses at the
prefrontal cortex in SZ may be mediated
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by dopamine associated neurotoxic and
neurotrophic structural changes in the
dorsal heteromodal association areas.
Although the exact mechanism of
pathogenesis of schizophrenia has not
been established, numerous underlying
neurobiological mechanisms provide
insight into its complex disease process.
In contrast to simple Mendelian inheritance, the development of schizophrenia
is determined by a complex interaction
among multiple genes and environmental factors, including socioeconomic circumstances, education, family
structure, life stresses, and maternalfetal exposure to infection. Therefore,
emergence of psychopathology is rooted
in the interplay between genes and
environment and can be seen at the
level of molecular and cellular alterations resulting in dysregulations in

neural circuitry. The advancement of
psychiatric genetics, brain imaging,
cognitive and affective neuroscience,
and psychometric theory has furthered
our understanding of the etiology and
pathophysiology of psychiatric disorders
such that new treatment interventions
can be utilized.
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Identification of microRNAs Differentially Expressed in Urothelial Carcinoma
Bladder cancer
is currently the
fourth most
common cancer
type in the United
States, with over
70,000 new
cases and 14,000
Yasmin Akbari, MSI
deaths reported in
Advisor: Louis S. Liou, MD,
2009.1 Urothelial
Boston University School
carcinoma (UC),
of Medicine
the most common
form of bladder
cancer, affects the inner epithelial lining
of the bladder and, in severe instances,
invades the outer muscle layers. While in
most cases UC presents as a noninvasive
papillary tumor with good prognosis,
such low-grade urothelial tumors are
known for their high rate of recurrence,2
making them difficult and expensive to
treat.
MicroRNAs (miRNAs) are a recently
discovered class of short, non-coding
RNA molecules responsible for posttranscriptional fine-tuning of human
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gene regulation. Notably, miRNAs
appear to demonstrate differential
expression levels across various stages
of cancer and thus may play a role
in tumorigenesis, serving as either
oncogenes or tumor-suppressor genes.
Current research has shown that the
expression signature of miRNAs tends
to remain fairly consistent between cells
of a particular type and cancer stage,3
suggesting that a panel of miRNAs
differentially expressed in malignant
tissue may serve as diagnostic markers
for a given cancer type.
In this study, we propose such a
diagnostic panel of miRNAs that may
supplement existing UC diagnostic tests.
UC is traditionally diagnosed following
cystoscopy accompanied by histological
examination of urothelial tissue biopsy,
yet these methods do not always offer a
clear distinction between normal and
cancer phenotypes. Analysis of miRNA
expression in urothelial tissue may serve
as a powerful quantitative supplement
to largely qua litative c ystoscopy

exa mination, t hereby improving
confidence in diagnosis of UC.
RNA was extracted from 23 patient
tissue samples (eight normal urothelium,
eight high-grade UC, seven low-grade
UC) and quantified using RT-PCR.
Expression data was normalized using
U6 as an endogenous control. A twotailed t-test revealed a panel of 20
miRNAs differentially expressed in UC
tissue (p < 0.05), with 11 down-regulated
and the remaining nine up-regulated.
Among these 20 miRNAs, miR-143
appears down-regulated, supporting
existing research that implicates miR143 as a tumor suppressor in bladder
cancer.4 K-Nearest Neighbors and Naive
Bayes classifiers were generated using
this miRNA panel and demonstrated
reasonably high sensitivity (0.93 and
0.87, respectively) and specificity (0.88
and 1.00, respectively) in diagnosing
UC. ROC curves for each classifier
also suggested performance well above
random guessing and with high accuracy.
However, the majority of the miRNAs
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that comprise this panel (16 out of the
20) have not been implicated in UC
or any other urological cancers when
queried in PubMed. Currently our
collection of 20 miRNAs performs well
as a diagnostic panel for UC in our
patient set and may be appropriate for
larger populations. Future studies will
need to explore any causative role of these
20 miRNAs in UC via cell culture study
and analysis of potential gene pathway
targets in order to help confirm their
diagnostic validity.
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miRNA

p-value

Fold Change

Expression in Cancer

hsa-miR-125a
hsa-miR-125b
hsa-miR-127
hsa-miR-138
hsa-miR-143
hsa-miR-146a
hsa-miR-197
hsa-miR-198
hsa-miR-222
hsa-miR-23a
hsa-miR-365
hsa-miR-375
hsa-miR-376a
hsa-miR-515-5p
hsa-miR-521
hsa-miR-569
hsa-miR-587
hsa-miR-611
hsa-miR-96

0.026
0.042
0.042
0.014
0.048
0.066*
0.018
0.032
0.022
0.048
0.042
0.016
0.018
0.028
0.047
0.040
0.020
0.006
0.024

0.227
0.312
0.406
21.859
0.276
0.305
0.460
0.370
0.228
0.399
26.052
0.097
0.186
25.516
6.176
26.237
22.454
9.962
5.195

Lower
Lower
Lower
Higher
Lower
Lower
Lower
Lower
Lower
Lower
Higher
Lower
Lower
Higher
Higher
Higher
Higher
Higher
Higher

TABLE: 20 miRNAs differentially expressed in urothelial carcinoma (UC) tissue as compared with normal urothelium.
All miRNA fold increases/decreases are significant (p<0.05) with the exception of hsa-miR-146a marked with an (*).

Using a FACS-based Assay to Measure Dengue Virus Infection
of DC- and L-SIGN Cells in the Presence of Neutralizing Antibodies
Dengue virus
(DEN V ) is a
worsening arboviral disease
endemic to countries in Central
and South
Kate Poropatich, MSII,
America, Africa,
Butsaya Thaisomboonsuk,
and South and
PhD, United States Army
Southeast Asia.
Medical ComponentMechanisms of
Armed Forces
DEN V in fecResearch Institute
tion and disease
of Medical Sciences
pathogenesis
(USAMC-AFRIMS),
remain incomAdvisor: Stephen Thomas,
ple te ly u nderMD, USAMC-AFRIMS
stood. Cellular
receptors for
DENV may impact infection dynamics
and subsequent clinical disease severity.
Dendritic cell (DC) subsets express
the DC-specific intracellular adhesion
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molecule (ICAM) 3-grabbing nonintegrin (DC-SIGN) allowing direct
infection of DCs by a number of
pathogens. DENV has four serotypes,
all of which use DC-SIGN (CD209), a
C-type lectin, to infect DCs.1 L-SIGN is
largely expressed on endothelial cells in
liver sinusoids.2 In cell culture, human
DCs become susceptible to DENV
infection following transfection with
DC- or L-SIGN. Primary human DCs
naturally expressing DC-SIGN as well
as monocytic cell lines transfected with
DC- or L-SIGN facilitate cellular infection, release and propagation of infectious DENV virions.1 For this reason,
DC-SIGN and L-SIGN are attractive
for use in assays assessing cellular infection or prevention of infection.
To better understand how cellular
receptors may influence infection in
the presence of pre-existing neutralizing

antibodies (NAb’s), we studied preillness serum samples from Thai subjects who subsequently experienced
infection with the DENV-1 serotype.
A fluorescence-activated cell sorting
(FACS)-based assay was used to explore
neutralizing capabilities of pre-illness
serum samples mixed with DENV in
the presence of B cell lymphoblastoid
Raji cells transfected with either DC- or
L-SIGN receptors. Antibody neutralization was performed by incubating
serially diluted test and control patient
sera with DENV in 96-well roundbottomed culture plates for 30 minutes.3 Subsequent DENV infection was
performed by adding serial dilutions of
DC- and L-SIGN cells to the plates and
incubating them overnight. This assay
allowed us to quantify the antibody
neutralizing capacity of infected patients
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L- and DC-SIGN cellular receptors
may increase understanding of DENVcellular interactions and host NAb
immune profiles. This is especially
important for quickly and effectively
measuring anti-DENV NAb’s of large
numbers of sera from recipients of
clinical trial DENV vaccines in order
to measure their efficacy in stimulating
host humoral immune responses. The
classic PRNT requires four to seven
days to complete, making it less practical for quickly generating results when
compared to the FACS-based assays that
takes two days to complete.

FIGURE: Neutralizing antibody (NAb) attachment to DENV blocks attachment to Fc-γ-R on monocytes, thereby
blocking infection. The same may be true for DC- and L-SIGN lectin receptors expressed on dendritic cells (DCs).4

DENGUE VIRUS Continued from p. 9
by using flow cytometry to measure
the number of DC and L-SIGN cells
infected in the presence of their NAb’s.
In total, we tested sera from 18 subjects who became infected with dengue
and experienced a spectrum of dengue
disease severities (non-hospitalized
dengue fever, hospitalized dengue
fever, hospitalized dengue hemorrhagic
fever). The anti-DENV NAb titer in
the sera was determined by calculating

the dilution of sera at which point 50%
of the DENV input was neutralized.
Titers were determined for each sample
in the presence of DC- and L-SIGN
cells. A third neutralizing antibody
titer was determined using the goldstandard plaque reduction neutralizing
test (PRNT). The above experiments
are being repeated in ongoing experiments with pre-illness sera samples from
subjects who experienced DENV-2,
DENV-3, or DENV-4 infections.
The FACS-based assay using DENV
permissive cell lines transfected with

REFERENCES:
1.

TASSANEETRITHEP B, BURGESS TH, GRANELLI-PIPERNO
A, TRUMPFHELLER C, FINKE J, SUN W, ET AL. (2003).
DC-SIGN (CD209) Mediates Dengue Virus
Infection of Human Dendritic Cells. J Exp Med,
197, 823–29.

2.

CORMIER EG, DURSO RJ, TSAMIS F, BOUSSEMART MANIX
C, OLSON WC, ET AL. (2004). L-SIGN (CD209L)
and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus. PNAS,
101,14067–72.

3.

MARTIN CN, PARDO J, SIMMONS M, TJADEN J A, WIDJAJA
S, MAROVICH MA, ET AL. (2006). An immunocytometric assay based on dengue infection via
DC-SIGN permits rapid measurement of antidengue neutralizing antibodies. J Virol Methods,
134,74–85.

4.

WHITEHEAD SS, BLANEY JE, DURBIN AP, MURPHY BR.
(2007). Prospects for a dengue virus vaccine.
Nature Reviews Microbiology 5,518–528.

Brain Tumor Stem Cells Isolated from a RasB8 Transgenic
Murine Model Provide a Working Stem Cell Model for Malignant Glioma
Astrocytomas are
the most common
primar y tumor
a f fecting the
adult CNS, with
grade IV, known
as Glioblastoma
Multiforme
Kristen Batich, MSII
(GBM ), b ei n g
Advisor: Duane A. Mitchell,
MD, PhD, Duke University
the most lethal
Medical Center
(12 –15 mont h
1
median survival).
Specific adjuvant therapies in various
astrocytoma models have been applied
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in the clinical setting. 2,3 However,
the development of effective targeted
therapies for GBM is heavily dependent
on the investigation of its pathogenesis
via appropriate preclinical models
that closely reproduce the clinical and
histologic characteristics of human
astrocytomas.
Currently there is limited understanding of the relative contribution
of particular glioma cells to overall
tumor growth. Recent studies have
demonstrated a small fraction of cells
displaying features of primitive neural

progenitor cells with tumor-initiating
potential, termed glioma stem cells
(GSCs).4 One current debate is that the
glioma immunophenotype varies, thus
additional markers for GSCs are needed
to improve their isolation. One well
accepted marker for GSCs is CD133, a
cell surface marker expressed on progenitors of hematopoietic and endothelial
cell lineages. GSCs sit at the forefront of
the cancer stem cell hypothesis, which
suggests that only a small fraction possesses the ability to self-renew and maintain the tumor, while most cells forego
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these two abilities as they differentiate
into cells that become the phenotypic
signature of the neoplasm. Current
treatments aim to debulk tumors but
fail to target GSCs leading to treatment failure, recurrence, and ultimately
mortality. Detecting these keystone cells
in GBMs will provide insight into the
mechanism of tumorigenesis and aid in
the development of more precise treatment modalities.
We used an invasive mouse astrocytoma model generated by stem cell transgenesis of an activated 12V-Ha-RAS
gene under regulation of the human glial
fibrillary acidic protein promoter.5 This
model allowed us to describe the proliferative and tumorigenic characteristics
of GSCs. Astrocytoma lines contained a
significant proportion of CD133+ cells,
the majority of which expressed CD44,
a marker present on neural stem cells
and human GBM cells. Furthermore,
a subpopulation of lineage negative
(CD133+/44-) cells represented ~3% of
the tumor population. One requisite of
detecting GSCs is that, when sorted and
plated at a single cell density per well, the
cell must have the capacity to generate
free-floating clusters of clonally derived
progeny, called tumorspheres, and its
description is based on the phenomenon
of neurosphere formation that occurs
with non-cancerous neural stem cells.
CD133 + cells demonstrated greater
tumorsphere formation and self-renewal
via secondary tumorsphere formation
after disruption of primary spheres
compared to CD133- cells. CD133- cells,
however, divided more extensively in
culture than CD133+ cells, supporting
the notion that CD133+ GSCs proliferate at a slower rate than differentiated
CD133- cells. CD133+ cells also showed
enhanced tumorigenicity in vivo compared to CD133- cells isolated from the
same tumor (Figure 2).
Here we described a subset of tumor
cells derived from a transgenic model
that addressed which of the morphologically diverse tumor cells could maintain
tumor initiation and survival. Three
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FIGURE 1: GSCs in malignant astrocytomas. GSCs comprise a fraction of tumor cells and are thought to arise
from either neural stem cells or specific differentiated cells which revert to stem cells. GSCs have been shown to be
resistant to chemo-radiation modalities and may be responsible for highly recurrent GBMs. [Setoguchi, T., Taga T.,
Kondo, T. 2004].

findings suggest that these CD133+ cells
were GSCs: they (1) generated clusters of
clonally derived cells resembling tumorspheres, (2) underwent self-renewal after
tumorsphere dissociation, and (3) differentiated to recapitulate the phenotype of
the tumor from which they originated.6

Because these GSCs must be targeted
to eliminate the possibility of recurrence, our findings aid in the search to
identify and isolate GSCs in the clinical
setting. With a greater understanding of
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FIGURE 2: A). FACS analysis revealed a population of CD133+ cells present in tumor lines of V12: Ha-ras-GFAP

transgenic mice, in particular, a subpopulation of lineage negative CD133+ cells. B). Astrocytoma cells were stained
with anti-CD133 monoclonal antibody and separated using Miltenyi Biotech anti-biotin beads and AutoMACS. Highly
purified populations of CD133+ and CD133- cells were obtained (middle panel). Bottom panel shows that CD133+
cells gave rise to equivalent numbers of CD133- and CD133+ progeny after expansion in vitro while sorted CD133- cells
remained CD133- (>90%). C). Formation of highly invasive intracranial astrocytomas by CD133+ tumor cells from
V12:Ha-ras-GFAP transgenic mice. Mice injected with CD133- cells exhibited no tumor growth (top panel) while 5/5
mice injected with CD133+ cells exhibited extensive growth of infiltrative tumor (bottom panel).
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GSC properties, including resistance to
various chemo-radiation therapies, we
will possess greater insight to develop
novel therapies for effectively eradicating
GBM.
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Cystathionine-γ-Lyase: A Target for Septic Shock
Septic shock
induced
morbid it y a nd
mortality, which
i s a r e s u lt o f
cardiovascular
collapse and
multisystem
Monica Gupta, MSIII
organ failure, may
Advisor: Dan E.
be attributed to
Berkowitz, MD, Johns
vasodilation and
Hopkins University School
hypotension. This
of Medicine
leads to impaired
vasoregulation,
microcirculatory dysfunction, shunting,
and critical organ hypo-perfusion.
Hydrogen sulfide (H 2 S), previously
known to be produced by cystathionineγ-lyase (CSE), and also known to be a
toxic gas, has been identified as a gaseous
transmitter, like nitrous oxide (NO),
which promotes vasodilation.1 This
is likely done by hyperpolarization of
vascular smooth muscle. Plasma H2S
levels are known to be elevated following
CSE upregulation/activation in sepsis.2
We tested the hypothesis that this
excess in H2S production contributes
to vasoplegia and capillary leak due to
enhanced endothelial cell permeability,
and subsequent organ hypoperfusion,
microcirculatory failure, hypotension,
and death.
To do this, age matched wild type
(W T) and CSE knockout (CSE -/-)
mice were exposed to a septic stimulus
[25mg/kg intraperitoneal LPS injection
or Cecal Ligation Puncture (CLP) ].
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FIGURE 1. Because the degree of hyporesponsiveness to PE was significantly less attenuated in CSE-/-+LPS (25.40%

reduction) than in WT+LPS (55.60% reduction) as compared to their control counterparts, the findings supported our
hypothesis that vascular hyporesponsiveness in sepsis is mediated by CSE-dependent H2S.

The animals were sacrificed 12 hours
following LPS injection or 24–36 hours
after CLP, and mesenteric arteries (MAs)
were dissected. Mesenteric arteries
excised from W T mice that were
sacrificed 24–48 hours after CLP were
then placed in organ chambers, exposed
to phenylephrine (PE), an α1 agonist,
and vascular reactivity studies were
performed. Contractile responses were
measured by the changes in isometric
tension of the mesenteric rings using
a digital force isometric transducer
connected to a data acquisition system.

Vasocontractile responses showed a
markedly attenuated contractile response
to PE (WT CLP, Emax ~130.926% vs
WT, Emax ~259.564%), with Emax
measuring the maximum contractile
response. In WT- CLP MAs the PE
response was 50.44% compromised
while totally preserved in CSE-/-.
It was further found that there
was no difference in response between
CSE-/- and untreated WT mice in the
CLP model. Phenylephrine responses
(tension calibrated in mg units) were
also attenuated in WT+LPS (LPS treated
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WT mice) compared to WT (n = 5,
Emax ~308 mg vs Emax ~694 mg).
In addition, there was attenuation of
the depressor response in CSE -/-+LPS
(LPS treated CSE -/-) as compared to
CSE-/- control mice (n = 5, Emax~789.6
vs Emax~1059).
Cell-sensing impedance substrate
(ECIS) technology, a highly sensitive
method quantif ying permeability,
further demonstrated that exposure of
human lung microvascular endothelial
cells to pathophysiologic levels (1mM)
of H 2 S (as seen in sepsis), caused a
significant decrease in average barrier
resistance (cell-cell and cell-matrix),
but not at physiologic levels (100μM).
In the first 96 hours of sepsis induction,
mortality studies with CSE models of
CSE -/- and WT mice demonstrated a
60% survival benefit in CSE-/-.
In conclusion, genetic deletion
of the H 2 S forming enzyme, CSE,
protects mice from vasoplegia and
vascular endothelial permeability and
more importantly has survival benefits
in sepsis. Accordingly, CSE inhibitors

FIGURE 2. CSE -/- mice are shown to be protected from vasoplegia and have increased survival in sepsis.
the cardiovascular system. Current vascular
pharmacology, 4(1), 17–22.

may have therapeutic potential in sepsis
therapy.
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In Vivo Persistence of Redirected T Cells Transduced
at Decreased Oxygen Concentrations
Adoptive T cell
therapy (ACT )
has emerged as
a n impor t a nt
strategy to
m e d i a t e a nt i tumor immunity.
As demonstrated
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T cells redirected
against a target
tumor antigen via introduction of
a chimeric antigen receptor (CAR)
or an ectopic TCR. Importantly,
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successful ACT requires that the
transduced lymphocytes expand, persist
and function in vivo.1 It has been
hypothesized that this therapeutic
strategy is often compromised by the ex
vivo transduction protocol. Specifically,
to date, donor T cells have always been
transduced at 20% oxygen, although
physiological O 2 concentrations in
lymphoid organs range from 2–5%.2
High oxygen concentrations could
potentially alter multiple parameters
including T cell differentiation, gene
expression, as well as in vivo expansion
and function.
Here we address the above concerns
by comparing the in vivo fate of cells
transduced ex vivo under physiological
(2%) and atmospheric (20%) oxygen
conditions. Toward this goal, we

engineered lymph-node (LN) T Cells
from a congenic strain of donor mice
(Thy1.1+) to express a CAR specific
for the human CD19 antigen fused to
a T-cell receptor CD3-zeta signaling
chain.3 Expression of the CAR was done
using mouse leukemia virus (MLV)mediated transduction in either 20% or
2% oxygen culture conditions.
To assess the in vivo efficacy of
ACT-mediated tumor prevention, host
mice were injected subcutaneously
with 4x10 5 mouse lymphoma cells
(EL-4 cell line) expressing the huCD19
antigen. On the same day, CA Rtransduced donor T Cells were labeled
with Carboxyfluorescein succinimidyl
ester (CFSE), a cytosolic dye used to
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monitor lymphocyte proliferation in
vivo, and 7x10 6 cells were injected
intravenously into host mice. Following
ACT, tumor growth was assessed on
days 10, 13, 17, and 21 and mice were
sacrificed at days seven and 21. Lymph
nodes and spleens were harvested and
the cell suspensions were analyzed
by f low cytometry. Factors assessed
included transduction efficiency, donor
T-cell survival, proliferation, and
differentiation.
We demonstrate that ex vivo gene
transfer efficiency was comparable at
2% and 20% O2 in engrafted donor
cells recovered from hosts’ LNs (Figure
2a). Donor huCD19-specific T cells
transduced at both 2% and 20%
O2 prevented tumor development as
compared to hosts that received nontransduced (NT) cells cultured at similar
conditions (Figure 1). Interestingly, the
phenotype of the redirected T cells was
altered. Cells transduced at physiologic
oxygen resulted in modified CD4:CD8
ratios (Figure 2b), associated with
a decreased proliferation (data not
shown) and percentage of CD4+ T Cells
with an effector phenotype (CD44+,
CD62L -) (Figure 2c). While the overall
persistence and differentiation of
the transduced cells was markedly
modified by the oxygen concentration
to which cells were exposed during the
transduction period, it is notable that

FIGURE 1: Adoptive transfer of CAR-transduced T cells specifically prevents tumor growth in lymphodepleted hosts.
Prior to adoptive transfer, donor LN T-cells were transduced with a huCD19-specific CAR at 20% O2 (CAR 20%), 2%
O2 (CAR 2%) or not transduced, but cultured under similar conditions at 20% O2 (NT 20%).

these phenotypic differences had little
effect on the recovery of transduced T
cells following adoptive transfer into
pre-conditioned mice (data not shown).
Our studies demonstrate that
oxygen concentration during ex vivo
transduction protocols has a significant
effect on transduced donor lymphocytes.
These f indings can potentially be
of therapeutic va lue in AC T for
malignancies as transducing T cells
at a more physiological concentration
i mprove s t hei r p er si s tenc e a nd
functionality.
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FIGURE 2: Phenotype of engrafted (Thy1.1+) donor cells recovered from hosts LN. Donor T cells were stimulated for 48 hours by anti-CD3/anti-CD28 mAbs, under either

20% or 2% oxygen culture conditions. MLV-mediated transductions were performed on fibronectin-coated plates. (A) Gene transfer efficiency was assessed by monitoring huCD34
gene expression-marker by FACS. (B) CD4 and CD8 expression of transduced (huCD34+) and non-transduced (huCD34-) recovered cells. (C) CD44 and CD62L expression of
CD4+-gated cells on day seven post-transfer.
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In vivo Imaging of the Cannabinoid CB1 Receptor
Using Positron Emission Tomography
The actions of
marijuana (cannabis) are mediated by receptors
(pr i m a ri ly t he
cannabinoid CB1
re c e ptor) t h at
Garth Terry, MSIV, PhD
have unusually
Advisors: Robert Innis,
high density and
MD, PhD, National
wide distribution
Institute of Mental Health,
1
in the brain. In
and Christer Halldin, PhD,
addition to mediKarolinska Institute,
ating the effects of
Stockholm, Sweden
exogenous drugs
l i k e c a n n a bi s ,
these receptors also receive signals from
endogenous cannabinoids (endocannabinoids), which modulate the release
of several other neurotransmitters. Since
abnormalities of cannabinoid receptors
and endocannabinoid transmission have
been hypothesized to underlie disorders
of the brain (e.g., memory impairment,
schizophrenia, and seizures), this neurotransmitter system has been an active
target for development of drug therapies
and of biomarkers to measure its in vivo
function. Positron emission tomography
(PET), which can image the distribution
of receptors in the body, is a powerful
tool for drug development, and can
quantify the receptor as a biomarker to
assess pathophysiology.2 The purpose of
these studies was to evaluate several candidate PET radioligands for their relative
ability to quantify CB1 receptors in the
living brain of animals and humans.
We first assessed [11C]MePPEP as
a PET radioligand through studies in
rodents.3 Wild-type and genetically
modified mice were used to determine
that [11C]MePPEP is not a substrate for
the P-glycoprotein efflux transporter
and that the majority (about two-thirds)
of its binding in brain is specific to the
CB1 receptor. Pharmacologically active
doses of CB1 agonists had no effect on
[11C]MePPEP in rats, which suggests a
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FIGURE 1: [11C]MePPEP can be displaced by antagonist, and not by agonist, in rodent brain. Drugs were

administered IV to rats 40 min after [11C]MePPEP. Compared to the baseline curve (■) inverse agonist rimonabant
(❍) displaced the majority of radioligand, whereas agonists anandamide (Δ), methanandamide (∇), CP 55,940
(◊), URB597 (anandamide reuptake inhibitor, ×), and URB597 with anandamide (+) were unable to displace the
radioligand.

large CB1 receptor reserve (Figure 1).
Pharmacokinetic modeling of CB1
receptors using brain radioactivity and
measurements of radioligand in arterial
plasma yielded stable measures after
70 minutes of scanning. The results
suggest that [11C]MePPEP might be successful in humans, although competition
studies with endocannabinoids would
not be possible, and radiometabolites
might cause consistent overestimation
of CB1 receptor density.
Second, we examined [11C]MePPEP
in healthy human subjects using the
“gold standard” of compartmental
modeling to quantify receptor density
in brain. 4 [11C]MePPEP had high
uptake in brain, could be imaged for
210 minutes, and could quantify CB1
receptors within about 60 minutes
of scanning. However, the accuracy
and precision of the pharmacokinetic
modeling hinged upon the accuracy of
radioligand measurements in arterial
plasma. A radioligand with a longer
radioactive half-life, such as from 18F,
would be expected to provide superior
measurements in arterial plasma.

We t h e n e v a l u a t e d s e v e r a l
F-radiolabeled analogues of MePPEP
in monkeys. [18F]FMPEP-d2 was selected
for study in humans due to its superior
uptake in brain compared to [18F]FEPEP,
and reduced uptake of radioactivity in
bone compared to [18F]FMPEP.5 In
humans, [18F]FMPEP-d 2 could image
and quantify CB1 receptors with better
accuracy and precision compared to
that of [11C]MePPEP. As suspected, the
accuracy in measuring radioligand in
arterial plasma was the critical improvement needed in the pharmacokinetic
modeling.
Finally, we examined the biodistribution and estimated the dose of radiation
that would be received in human studies
using [11C]MePPEP and [18F]FMPEP-d2.6
Both radioligands had high uptake in
the brain, liver, and lungs, and both had
significant uptake of radioactivity in the
bone marrow, but not in bone (Figure
2). Regardless, both radioligands have
an effective dose similar to that of other
clinically used PET radioligands.
18
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In conclusion, we have shown
that both [11C]MePPEP and [18 F]
FMPEP-d 2 can quantify CB1 receptors
in brain. However, [18F]FMPEP-d 2 is
superior to [11C]MePPEP because it has
greater precision and accuracy. Thus,
[18F]FMPEP-d 2 is a promising PET
radioligand to measure CB1 receptors
in vivo, and can now be used to explore
the role of this receptor in human health
and disease.
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Spontaneous Uveitis in the Absence of IFN-g in Transgenic Mice
Expressing a Retina-specific T cell Receptor
Experimental
autoimmune
u ve it i s ( E AU )
serves as an
animal model of
human uveitis.
In mice, the
Neena Passi, MSII
c l a s s ic a l E AU
Advisor: Reiko Horai, PhD,
model is induced
National Eye Institute
by immunization
with retina l
antigens such as interphotoreceptor
retinoid binding protein (IRBP) in
complete Freund’s adjuvant and in
many cases with injection of pertussis

16

toxin as an additional adjuvant. A new
transgenic mouse strain expressing a
T cell receptor specific for IRBP161-180
(IRBP TCR Tg) has recently been
developed in our laboratory.1 The IRBP
TCR Tg mouse spontaneously develops
EAU-like ocular inflammation with
early onset, providing a useful model to
study the basic mechanisms of uveitis.
Interferon-gamma (IFN-g) and
interleuken-17 (IL-17) are two major
cytokines involved in T cell effector
functions and autoimmunity. Our
previous studies showed that systemic
neutralization of IFN-g exacerbated

EAU,2 and IFN-g deficient (GKO) mice
developed EAU comparable to their
wild-type counterparts.3 A more recent
study showed increased production of
IL-17 in lymph nodes and in uveitic eyes
of GKO mice.4 These results suggest
that IL-17-producing Th17 cells might
serve as pathogenic effector cells in
GKO mice.
In this study, to further investigate
the roles of IFN-g and IL-17 in the
development of uveitis, we sought
to e va lu ate t he de velopment of
spontaneous uveitis in the absence
of IFN-g. GKO mice were crossed
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FIGURE 1: IRBP TCR Tg-GKO mice spontaneously develop EAU-like uveitis with less severity than IRBP TCR Tg mice.
Left, EAU scores of wild-type (Non-Tg), IRBP TCR Tg (Tg-Gwt), IRBP TCR Tg-GHet and IRBP TCR Tg-GKO mice between
four and seven months old determined by histopathology. Scores were assigned on a scale of 0 to 4, according to
the extent of inflammation and tissue damage. Each point represents one mouse (average of both eyes).
! (p<0.05).
Right, Kinetics of disease onset in Tg-Gwt, Tg-GHet and Tg-GKO mice based on weekly fundoscopy readings. Tg-GKO
mice showed similar disease incidence as their heterozygous and wild-type counterparts.
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Kinetics of Disease Onset

IFN-γ (pg/ml)

with the IRBP TCR Tg mice and
their disease progression and cellular
responses were examined. Fundospic
and histopathologic analysis were
used to monitor retinal inflammation
and disease progression. IRBP161-180 specific lymphocyte proliferation was
assessed with [3H]-Thymidine staining.
IFN-g and IL-17 production in culture
supernatants were analyzed by ELISA.
Our study revealed that IRBP TCR
Tg-GKO mice develop spontaneous
uveitis with similar incidence, but
less severity than their heterozygous
(IR BP TCR Tg-GHet) and wildtype (IRBP TCR Tg) littermates,
suggesting that IFN-g is dispensable
for disease onset but may have a role in
disease progression (Figure 1). Lymph
node cells and splenocytes from the
IRBP TCR Tg GKO mice exhibited
comparable proliferation responses to
IRBP161-180 as compared to their wild
type controls, supporting previous
findings that IFN-g is not required for
priming pathogenic T cells (Figure not
shown). Lymphocytes from IRBP TCR
Tg-GKO mice produced more IL-17
than those from the IRBP TCR Tg
mice, suggesting that IL-17-producing T
cells may play a role in the development
of uveitis in IRBP TCR Tg-GKO mice
(Figure 2). Further studies are needed to
elucidate the roles of IFN-g and IL-17 in
the development of autoimmune uvietis.

Tg-GKO

FIGURE 2: TCR Tg-GKO mice produce IL-17. Culture supernatants of lymph node cells and splenocytes were
stimulated with IRBP peptide (1μg/mL) were collected and measured for IFN-g (left) and IL-17 (right) by ELISA.
Tg-GKO cells produced no detectable IFN-g as expected, whereas parallel supernatants for the other TCR Tg genotypes
contained significant amounts of IFN-g. There was no significant difference in the amount of IFN-g produced by Tg-Gwt
and Tg-GHet mice. Measurements of IL-17 in the same supernatants showed that Tg-GKO mice produced more IL-17
than the wild-type controls and Tg-GHet mice; however, these differences were not statistically significant.
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Appropriate Role of Aprotinin in Thoracic Aortic Surgery: Should We Have it Back?
Thoracic aortic
surgery, with or
w it hout deep
hypothermic
arrest, is an
inherently
precarious
Andrew Zhang, MSII
cardiac operation
Advisor: John Elefteriades,
characterized
MD, Yale Center for
by aberrat ion s
Thoracic Aortic Disease
i n t he nor m a l
properties of
blood. These alterations in hemostasis
and thrombogenesis are associated with
particularly increased rates of stroke
and mortality, and consequently, there
is a need to finely control postoperative
bleeding in this subset of surgeries.1,2
The safety of aprotinin use in cardiac
surgery has been heavily debated,
both before and after its withdrawal
by the FDA in 2007. Concerns have
centered on putative excess thrombosis,
embolism, and renal failure.3,4,5,6 A pilot
study at our institution suggested that
in thoracic aortic surgery, aprotinin, an
antifibrinolytic serine protease inhibitor,
was safe and effective for conventional
use in these operations.7 The aim of
this investigation was to determine if
a larger cohort would confirm safety
and efficacy of aprotinin in thoracic
aortic surgery. In this case-control
study, we demonstrate that the use
of aprotinin offers all benefit and no
liability in thoracic aortic surgery.
Patients undergoing surgery for thoracic
aneurysm or dissection at Yale-New
Haven Hospital between 1995 and
2010 were considered for inclusion
in this study. 183 patients receiving
aprotinin during this time period
were each matched with 183 controls
based on preoperative criteria (age,
gender, urgency of surgery, location of
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Outcomes
24 Hr Drainage
RBC transfusion
FFP transfusion
Platelet transfusion
Total ventilation (min)

Aprotinin (n=183)
590.4¬±290.9
1.84¬±2.36
1.75¬±2.36
0.78¬±1.36
1403¬±1834

Control (n=183)
763.4¬±470.8
2.5¬±2.97
2.26¬±3.64
1.54¬±2.07
1992¬±3210

P-value
0.0001*
0.01*
0.11
0.0001*
0.03*

FIGURE: Unpaired analysis for continuous clinical variables.
* denotes statistical significance

aneurysm) for a total enrollment of 366
as compared to those that did not. The
patients. Pre- and post-operative data
results of this study lead us to believe
were collected from the medical records
that aortic surgery and aprotinin may
of aprotinin patients and their matched
be especially suited to each other. We
controls. Success of matching was
simply did not find the purported
assessed by bivariate analysis and then
deleterious effects associated with this
clinical outcomes analyzed. Among
drug. Thoracic aortic surgical patients
t he 366 subject s
enrolled in this study,
The results of this study lead us to believe
aprotinin patients
that aortic surgery and aprotinin may be
showed signif icant
benefits compared to
especially suited to each other.
controls in 24-hour
chest tube drainage,
are likely suffering from aprotinin
RBC transfusion, platelet transfusion,
withdrawal, and its reinstatement
and total ventilation time (see figure).
for this specific indication should be
There were three cases of renal failure
considered.
in aprotinin patients and one in controls
while there were also seven embolic
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Use of Musculoskeletal Ultrasound to Diagnose
and Treat Symptomatic Sacral Bursitis: a Case Report
epidural injection. For pain refractory
to treatment after four weeks, surgical
evaluation is indicated.2
Bursitis has been shown to mimic
lumbosacral radiculopathy at multiple
locations including the piriformis
bursa,3 trochanteric bursa,5 and iliopsoas
bursa.4 Swezey et al suggests that this is
common in an elderly population, with
thirty-one out of seventy patients having
bursitis versus radiculitis.
In the United States, MRI is the
imaging study of choice for diagnosis of
bursitis.7,8 Ultrasound
The United States Agency for Health Care has also been shown
to be ef fec t ive in
Research and Quality guideline specifies MRI diagnosis of bursitis
compared with MRI
as the modality of choice for suspected spinal but less detailed.6,9 In
Europe, ultrasound is
soft tissue damage, such as radiculopathy.1
the study of choice for
the identification of
iliopsoas bursitis due to its lower cost
Epidural injections were ineffective in
versus MRI.9
relieving pain. Upon referral to this
To our knowledge, this is the first
practice, an ultrasound examination
case reported in the literature where MRI
demonstrated a large sacral bursa
failed to identify bursitis. As morbidity,
compressing the sciatic nerve, which was
mortality, and cost associated with
not apparent on pelvic MRI. This bursa
surgery are high, it may be reasonable
was drained and injected with cortisone,
to rule out bursitis prior to proceeding
resulting in pain resolution.
with surgical intervention. In addition,
The United States Agency for Health
due to the lower cost and in this case
Care Research and Quality guideline
report greater accuracy, ultrasound may
specifies MRI as the modality of choice
be preferable over MRI as an initial
for suspected spinal soft tissue damage,
diagnostic modality for bursitis as is
such as radiculopathy.1 A review article
done in Europe.
on lumbosacral radiculopathy states
that diagnosis should be confirmed with
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MRI or electromyography (EMG).2 If
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a disc herniation is found, it should be
Diagnostic imaging practice guidelines for
treated with a pain treatment plan or an
musculoskeletal complaints in adults-an
We r e p o r t a
c a se of a ma n
in his for ties
presenting with
radiating leg pain.
Radiculopathy
wa s d ia gnosed
Matthew Bean, MSIII
by a pr e v iou s
Advisor: Victor
physician based
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on Magnetic
Rehabilitation Hospital
Resonance
Imaging (MRI)
findings and physical examination.
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Robotic Radiosurgery for Inoperable Patients with Peripheral Stage IA
Non-Small Cell Lung Cancer: Local Control and Survival Using 5-mm Margins
Due to its typical
late clinical
presentation
a nd a g gre ssive
course, lung
cancer continues
to be the leading
Beant Gill, MSIV
cause of cancer
Advisor: Brian T. Collins,
mortality
MD, Georgetown
worldwide.
University Hospital
Lobectomy has
been established
as the primary curative option for
early-stage non-small cell lung cancer
( NSCLC) w it h f ive-yea r overa l l
survival rates between 60–80% and
loca l control rates ra nging from
5–11%, based on historical data.1
Nonetheless, many newly diagnosed
patients are older with multiple medical
co-morbidities, precluding them from
surgical management. Prior studies have
attempted to establish external beam

FIGURE 1: CyberKnife treatment planning with RTOG standard margins (left) and 5 mm margins (right).
The V15 is 76 cc and 53 cc, respectively.

of these studies, RTOG standard
margins were adopted for the clinical
treatment volume, which includes
1.0 cm longitudinally and 0.5 cm
axially. Our study aims to narrow these
margins and thus decrease normal
lung tissue damage, measured by
the volume receiving
Robotic radiosurgery with image guidance 15 Gray (V15), while
ma int a ining loc a l
offers a precise and effective treatment for control and overall
survival rates.
inoperable peripheral stage IA non-small cell
Inoperable patients
with biopsy-proven
lung cancer.
periphera l clinica l
stage IA NSCLC were
enrolled in this single institution study.
radiotherapy as a treatment modality
Three to five gold fiducial markers were
in early-stage, medically inoperable
implanted in or near tumors under
NSCLC; however, survival rates and
computed tomography (CT) guidance
toxicity associated with such treatment
1
to serve as targeting references. Gross
have been discouraging.
tumor volumes (GTVs) were contoured
The relatively new technique of
using lung windows and margins were
stereotactic body radiotherapy (SBRT)
expanded 5 mm circumferentially to
enables the delivery of high doses in
establish the planning treatment volume
few fractions. Several studies have now
(PT V ). Non-isocentric treatment
been conducted, providing evidence
plans were designed using hundreds of
of excellent local control rates and
pencil beams with a median collimator
improved overall survival with SBRT;
diameter of 25 mm. All treatments
toxicity remains a concern, however,
were delivered utilizing the CyberKnife
due to normal lung tissue exposure
2–4
system with Synchrony. Gross tumor
to radiation. Of note, in a majority
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doses ranged from 42–60 Gray (Gy) in
three equal fractions (BED Gy10 >100).4
Clinical examination and PET/CT
imaging were completed at six-month
intervals following treatment. The V15
was calculated using standard RTOG
margins and 5 mm margins (Figure 1).
Twenty-four patients with a mean
maximum tumor diameter of 2.2-cm and
a mean GTV of 10 cc were treated over
a four-year period. The mean calculated
V15 was 202 cc with a 5 mm margin
and 236 cc with the RTOG margins.
At a mean follow-up of 36 months, the
three-year Kaplan-Meier local control
and overall survival estimates were
95% and 79%, respectively (Figure 2).
Five patients with severe emphysema
(baseline post-bronchodilator FEV1 <
40% predicted) died of progressive lung
dysfunction following treatment.
Robotic radiosurgery with image
guidance offers a precise and effective
treatment for inoperable peripheral
stage IA NSCLC. Limiting the margin
to 5 mm decreased the V15 by an
average of 35 cc (range, 15–60 cc)
while preserving local control rates
comparable to published studies using
larger margins.3,4 The ability to spare
lung tissue is of great importance since
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progressive lung dysfunction was the
sole cause of death among this group
of patients.
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FIGURE 2: Kaplan-Meier curve demonstrating improved overall survival up to three years following treatment.

Washington, D.C., Metropolitan Area Distribution of Acute Chest Syndrome Episodes
Demographics of Pulmonary Complications
in Sickle Cell Disease
in Sickle Cell Disease Patients by Socioeconomic Status
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Sick le cell disease (SCD) is an
inherited blood
disorder that
affects multiple
organ systems,
with both acute
Kathy Chyjek, MSII
and chronic
Advisors: Suzanne van
manifestations.
Meer, MD, University
Pulmonary comMedical Center Utrecht,
plications are of
Utrecht, Netherlands, and
particular imporLewis L. Hsu, MD, PhD,
tance in patients
Children’s National
w it h SCD a s
Medical Center
t he y a re c ommonly associated
with high morbidity and mortality.1,2
Research suggests that children with
both SCD and asthma have higher morbidity as measured by more frequent hospitalizations for vaso-occlusive crises and
acute chest syndrome (ACS) episodes,
and as much as double the risk of mortality when compared to pediatric SCD
patients without asthma.3 Therefore, the
diagnosis of reactive airway disease in
pediatric SCD patients is clearly a poor
prognostic factor. However, it is currently
not known whether there is any degree of
modifiable risk associated with aggressive
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FIGURE: Washington, D.C., Metropolitan Area Distribution of Acute Chest Syndrome Episodes in Sickle Cell Disease
Patients by Socioeconomic Status.

empirical treatment of asthma in the
pediatric SCD population. Although
SCD disproportionately affects people of
African and Latino ancestry, the association between socioeconomic status and
prevalence of SCD is unknown.
This study investigated whether
socioeconomic status, as determined by
zip code distribution in the Washington
Metropolitan Area, correlates with reactive airway disease in pediatric SCD
patients as it does in asthmatic children
without SCD. A five-year retrospective
study examined randomly sampled 400
out of 950 total pediatric SCD patients
seen at Children’s National Medical

Center between 2008 and 2010. We
extracted hematological, pulmonary as
well as demographic patient information from electronic medical records
(Cerner PowerChart system). Median
household incomes from 2008 were
linked to zip codes in various regions
of the Washington Metropolitan Area
and results were then analyzed using
non-parametric statistical methods. The
Mann Whitney U test was used to determine differences in the characteristics
between pediatric SCD patients with
a diagnosis of reactive airway disease

SICKLE CELL

Continued on p. 22

21

SICKLE CELL

Continued from p. 21

versus those without a diagnosis of reactive airway disease.
Among the 400 pediatric SCD
patients, there was a strong inverse relationship between socioeconomic status
and the rate of acute chest syndrome
episodes (mean number of episodes
per patient per year). The rate of acute
chest syndrome episodes was 0.20 for
all of Washington DC (n=56), 0.15 for
Prince George’s County (n=147), 0.10
for Montgomery County (n=81), and
0.04 for Fairfax County (n=33), which
had median household incomes of $58k,
$72k, $94k, and $107k, respectively.
Acute chest syndrome episodes were

also significantly more prevalent in
children diagnosed with reactive airway
disease (18.75%) compared to those with
no history of asthma (p < 0.05).
Socioeconomic status as marked by
geographical distribution appears to be a
strong source of diversity in pulmonary
complications of pediatric SCD patients
in the Washington Metropolitan Area.
Our data is subject to the limitations
of a retrospective chart review, but it
effectively sets the stage for future prospective studies. Also, further analysis of
this data could account for differences
in the rate of acute chest syndrome episodes in SCD patients on hydroxyurea
or chronic transfusions, as opposed to
those not undergoing any treatment

for SCD. Lastly, the data can be useful
in planning service delivery, such as
evaluating whether a satellite pulmonary-hematology clinic might enhance
convenience of service for pediatric
SCD patients in the Washington, D.C.,
Metropolitan Area.
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Flat Blood Pressure Response to Exercise in Patients
with the Total Artificial Heart: The Feasibility of Cardiac Rehabilitation
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To t a l h e a r t
replacement is an
effective bridge to transplant for patients
with bi-ventricular heart failure and
is an alternative to implantation of
concomitant right and left ventricular
assist devices. The TAH consists of
two implantable pneumatic pumps
operating at a fixed ejection rate and
ejection pressure.1 Increases in cardiac
output during activity with TAH are
thought to be dependent on increased
venous return. The blood pressure
(BP) response to and safety of exercise
in patients with a TAH have not been
reported. We hypothesized that blood
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FIGURE 1: Scatter plots for blood pressure versus Metabolic Equivalents (METs) achieved.

Solid black circle = systolic blood pressure, Hollow circle = diastolic blood pressure.

pressure does not augment in response
to exercise in patients with a TAH.
Here we show that during circulatory
support with a TAH, there was a flat BP
response to exercise, meaning BP did

not significantly increase or decrease.
However, aerobic exercise training early
after device implant was safe and feasible
in a supervised setting. In this study,
30 patients participated in physical
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therapy and 22 of these patients
negatively correlated with
proceeded to participate
METs achieved during exerin treadmill rehabilitacise and the association was
tion. After TAH implant,
not statistically significantly
patients initiated physical
(systolic: β = -0.09, p = 0.3, diatherapy at a median of five
stolic: β = -0.14, p = 0.2) (Figure
days (IQR: four – seven days)
1). The maintenance of
and 22 patients began
systemic blood pressure
treadmill exercise
with activit y is
at a median of
possibly related
19 days (IQR:
to increased
13 – 35 days).
venous
The duration
return
of t re a d m i l l
(preload),
exercise (week
which in turn
1: 8.35 ± 3.29
increa se s t he
minutes vs. week 4:
stroke volume of
18.62 ± 9.07 minutes,
the right and left TAH
FIGURE 2: Total artificial heart pumps. Venous return
p < 0.001; week 1: 8.70
(courtesy of www.syncardia.com).
± 3.80 minutes vs. week
during exercise is facili8: 25.95 ± 15.06 mintated by the skeletal muscle
utes, p = 0.006) and the Metabolic
contraction, neurally mediated venoEquivalents (METs)6 achieved increased
contraction and respiratory pumps.2,3,4
Additionally, concomThe results of this study are pertinent as itant regional vasoconstriction in the
patient rehabilitation and mobility will be splanchnic and renal
beds helps maintain
of increasing concern as TAH patients will and augment systemic
blood pressure during
be free to go home in the near future.
exercise.5
This study demonstrates that patients with a TAH (1) have
over the course of rehabilitation (week
a flat blood pressure response to exercise,
1: 1.53 ± 0.13 METs vs. week 4: 1.85
(2) can safely participate in a physical
± 0.24 METs, p < 0.001; week 1: 1.53
rehabilitation program early after device
± 0.13 METs vs. week 8: 2.30 ± 0.52
implantation, and (3) exhibit improveMETs, p = 0.001). The BP’s before,
ment in exercise performance over the
during and post-exercise were similar
course of a rehabilitation program.
(120/69 ± 13/13 vs. 118/72 ± 15/10 vs.
These are the first data to describe the
120/72 ± 14/12 mmHg; systolic: p =
safety, implementation and efficacy of
0.3, diastolic: p = 0.1). The BP’s weakly
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a regimented physical rehabilitation
program for patients supported with an
artificial heart.
Currently in the United States,
patients with a TAH are bound to
inpatient wards of hospitals, as the
size and weight of the device prohibit
patient discharge. However, utilization
of a portable console is currently under
investigation. The results of this study
are pertinent as patient rehabilitation
and mobility will be of increasing concern as TAH patients will be free to go
home in the near future. Future patient
studies measuring multiple exercise
metrics with more intense exercise in a
prospective manner will provide further
guidance on rehabilitation for patients
with the device.
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Enoxaparin Treatment for Cerebral Venous Thrombosis in a Pediatric Patient
Cerebral venous
sinus thrombosis
(CVST) is a rare
but life threatening disorder in
children that has
been more readily
d ia gnosed a nd
Waleed Kurtom, MSIII
managed due to
Advisors: Richard Young,
enhanced neuroMD, GW Hospital,
imaging modaliand John F Hamilton,
t ie s, i mproved
MD, Inova Regional
identification of
Neurosurgery Service
risk factors, and
i ncre a sed c overage in the literature. Some risk factors
include head or neck infections, acute
systemic illness, hematologic disorders
and prothrombotic states including
homocysteinemia.1–2 Multiple studies
have shown that the most common sites
for thrombosis were the superior sagittal
sinus (55%), lateral or transverse sinuses
(51%), and the straight sinus (24%).1 Of
the numerous presentations of thrombosis, headache is reported in 90%
of cases.2 Following clinical suspicion
of sinus thrombosis, MRI and MRV
(Magnetic Resonance Venography) are
the gold standard diagnostic tools. 2
After the diagnosis has been established,
the majority of existing data supports
systemic anticoagulation as the initial
step in treatment. Patients with more
serious presentations or those with
clinical deterioration require direct
thrombolysis or surgical intervention
and anticoagulation.3–5 Anticoagulation
is typically achieved with heparin and
this is the medication of choice for the
majority of stable patients.6
Our case highlights a 14-year-old
right-hand-dominant female that presented for evaluation of a cerebellar
lesion. She had a recent history of
headache and vomiting and positive
dysmetria in her right upper extremity
on exam. Past medical history was
pertinent for premature birth and
colectomy secondary to necrotizing
enterocolitis. Upon admission, she was
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FIGURE 1A: Pre-Treatment. MR Venogram consistent
with thrombosis of the straight, right transverse, sigmoid
dural venous sinuses, the vein of Galen, and the internal
stable veins and the basal veins of Rosenthal as well as
the inferior sagittal sinus.

FIGURE 1B: Post-Treatment. There has been interval

partial recanalization of the right sigmoid, transverse
sinuses. There is also questionable minimal signal in the
vein of Galen with persistent thrombosis of the straight
sinus and the internal cerebral veins.

enoxaparin, glycerin suppository, and
vitamin B complex therapy. She presented at follow-up without complaints
of headache, nausea, vomiting or other
complications. Subsequent evaluation
showed elevated homocysteine levels.
This case illustrates the most evidenced-based management for a patient
with suspected venous sinus thrombosis.
The patient’s history of infantile gastrointestinal disease and homocysteinemia
are known risk factors for CVST. 2,9
Exam findings including headache and
vomiting prompted ordering a brain CT,
a valid initial imaging tool for cerebral
venous sinus thrombosis.7 Interestingly,
the team caring for this patient decided
to use enoxaparin prophylaxis after
surgery. Although enoxaparin is more
expensive than heparin, its once daily
dosing, and lower heparin induced
thrombocytopenia risk for patients with
good renal function made it a better
option in this case. Based on a literature
review and the outcome of our case, diagnosis and treatment of CVST remains
very difficult due to rarity of cases and
clinical variability.8–9 Further research
must be undertaken to determine the
effectiveness of treatment choices such as
enoxaparin as the best possible management for these patients.

noted to have a decline in mental status.
The patient was initially following commands but this function diminished soon
Although enoxaparin is more expensive than
thereafter. A head CT
showed a large right
heparin, its once daily dosing, and lower
cerebellar hemisphere
heparin induced thrombocytopenia risk for
infarct with right-toleft shift and tonsillar
patients with good renal function made it a
herniation secondary
to mass effect from
better option in this case.
the infarct. Right suboccipital craniotomy
REFERENCES:
with right cerebellar
1. DEVEBER G, ANDREW M. (2001). Cerebral sinovepartial lobectomy of necrotic brain with
nous thrombosis in children. N Engl J Med,
placement of a twist drill right frontal
345:417–423
ventriculostomy was performed by
2. STAM J. (2005). Thrombosis of the Cerebral Veins
neurosurgery. No complications from
and Sinuses. N Engl J Med, 352:1791–1798.
surgery were observed upon discharge.
3. EINHAUPL K, BOUSSER MG, DE BRUIJN SFTM, FERRO
The patient was sent home on colace,
JM, MARTINELLI I, MASUHR F, ET AL. (2006). EFNS

Fusion ✦ 2011

guideline on the treatment of cerebral venous
and sinus thrombosis. Eur J Neurol, 13:553–559.
4.

5.

MEDEL R, MONTEITH SJ, CROWLEY W, DUMONT AS. (2009).
A review of therapeutic strategies for the management of cerebral venous sinus thrombosis.
Neurosurg Focus, 27 E6:1–9.
RAHMAN M, VELAT GJ, HOH BL, MOCCO J. (2009).
Direct thrombolysis for cerebral venous sinus
thrombosis. Neurosurg Focus, 27 E7:1–8.

6.

BENTLEY JN, FIGUEROA RE, VENDER JR. (2009). From
presentation to follow—up: diagnosis and treatment of cerebral venous thrombosis. Neurosurg
Focus, 27 E4:1–7.

7.

ROLAND T, JACOBS J, RAPPAPORT A, VANHESTE R, WILMS
G, DEMAEREL P. (2010). Unenhanced brain CT is
useful to decide on further imaging in suspected
venous sinus thrombosis. Clinical Radiology, 65:
34–39.

8.

PFEFFERKORN T, CRASSARD I, LINN J, DICHGANS M, BOUKOBZA M, BOUSSER MG. (2009). Clinical features,
course and outcome in deep cerebral venous
system thrombosis: an analysis of 32 cases. J
Neurol, 256: 1839–1845.

9.

FILIPPIDIS A, KAPSALAKI E, PATRAMANI G, FOUNTAS
K. (2009). Cerebral venous sinus thrombosis:
review of demographics, pathophysiology, current diagnosis, and treatment. Neurosurg Focus,
27 E3: 1–11.

CyberKnife Radiosurgery for Previously Irradiated Vaginal Tumors
Va gina l recu rrences and the
subsequent development of metastatic disease is
a w e l l k now n
pattern of gynec olog ic a l c a nHuma Chaudhry, MSII
cers. Therefore,
Advisor: Brian T. Collins,
the primary goal
MD, Georgetown
of initial radioUniversity Hospital
therapy should be
Radiation Medicine
to prevent these
vaginal failures.
Patients presenting with primary
and recurrent vaginal tumors have
historically been successfully treated
with several weeks of conventionally
fractionated radiation therapy followed
by several days of inpatient low-dose
rate (LDR) intracavitary or interstitial
brachytherapy. To improve patient
tolerance of the therapy, researchers in
the past decade have developed effective outpatient high-dose rate (HDR)
brachytherapy protocols.5
Regardless of the method, brachytherapy is an invasive procedure associated with physical and psychological
discomfort and anxiety1-4 and chronic
bowel, bladder and vaginal toxicity.
The current standard treatment for
primary or recurrent vaginal carcinoma
usually involves external beam radiation
therapy (EBRT) and/or brachytherapy
(BT).5 EBRT generally decreases the
initial tumor size, and BT is used subsequently. BT is used for a small cancer
volume (i.e. less than 3 to 4 cm in
diameter) and requires inserting a radioactive source (or radioisotopes) directly
into or around the cancer. The highest
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Patient Age
			
1
45
2
89
3
57
4
65
5
68
6
56

Performance
Symptom
Status (ECOG) 		
0
Bleeding
2
Bleeding
0
Bleeding
2
Dysuria
0
Bleeding
0
Dysuria

Primary
Histology
Cancer		
Uterine
Papillary serous
Uterine
Adenocarcinoma
Uterine
Adenocarcinoma
Urethral
Adenocarcinoma
Uterine
Adenocarcinoma
Vaginal
Squamous cell

GTV (cc)
18.56
43.24
52.48
14.35
80.83
44.46

TABLE 1: Patient and Tumor Characteristics
GTV = Gross Tumor Volume; ECOG = Eastern Cooperative Oncology Group Performance Status reflects effect
of disease on patient’s daily life.9

radiation doses are delivered closest to
the radioactive source. BT may be either
intracavitary (sealed radioactive source
within a body cavity, i.e. the vagina) or
interstitial BT, a procedure that delivers
radiation using needles inserted into the
cancer and the surrounding tissues prior
to salvage therapy.6
The CyberKnife is a novel minimally invasive means of delivering
brachytherapy-like radiation dose distributions to vaginal tumors (Figure 1). We
report the clinical efficacy and toxicity
of salvage CyberKnife radiosurgery
for six patients with previously irradiated vaginal tumors not amenable to
brachytherapy.
Six consecutive women were treated
over a five-year period (Table 1). Two
patients presented with primary vaginal
tumors (vaginal squamous cell carcinoma and urethral adenocarcinoma)
and four with vaginal recurrences
(uterine endometriod adenocarcinoma
three and ovarian papillary serous
carcinoma). We found that four of the
six patients receiving > 30 Grays (Gy)
with the CyberKnife procedure had

a complete clinical response at three
months post-therapy. Cancers found in
two different patients (a primary vaginal
adenocarcinoma and a recurrent papillary serous uterine cancer) persisted at
three months and ultimately progressed
despite receiving 25 Gy of radiation. At a
median follow-up of 23 months, the twoyear Kaplan-Meier local control of tumor
growth and overall survival estimates
were 56% and 100%, respectively. No
severe (> grade 3) toxicities, defined as
late gastrointestinal complications, lifethreatening complications, or complications requiring surgery,8 were attributed
to CyberKnife treatment.7
Our results demonstrate that patients
with vaginal tumors, which were previously unresponsive to conventional
radiotherapy, may be successfully treated
with the CyberKnife radiosurgery
system. Further studies are needed to
investigate this novel therapy among
newly diagnosed patients. We believe
such studies may adapt the current
radiation treatment regimen of primary
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and recurrent vaginal tumors to include
CyberKnife as a first line treatment
modality.

REFERENCES
1.

KWEKKEBOOM KL, DENDAAS NR, ET AL. (2009). Patterns of pain and distress during high-dose-rate
intracavity brachytherapy for cervical cancer. J
Support Oncol, 7(3):108–14.

2.

WARNOCK C. (2005). Patients’ experiences of
intracavity brachytherapy treatment for gynaecological cancer. Eur J Oncol Nurs, 9(1): 44–55.

3.

BARROS GC, LABATE RC. (2008). Psychological repercussions related to brachytherapy treatment in
women with gynecological cancer: analysis of
production from 1987 to 2007. Rev Lat Am
Enfermagem, 16(6):1049–53.

4.

KUSHNER DM, FLEMING PA, ET AL. (2003). High
dose rate (192)Ir afterloading brachytherapy
for cancer of the vagina. Br J Radiol, 76(910):
719–725.

5.

BERIWAL S, HERON DE, ET AL. (2008). High-dose rate
brachytherapy (HDRB) for primary or recurrent
cancer in the vagina. Radiat Oncol, 13(3):7.

6.

SCHORGE JO, SCHAFFER JI, ET AL. Chapter 28.
“Principles of Radiation Therapy.” Williams
Gynecology: www.accessmedicine.com/content.
aspx?aID=3161261.

FIGURE 1: The CyberKnife LINAC is mounted on a robotic arm with six joints. One of the flat-panel amorphous
silicon detectors can be seen on the side of the treatment table. (Courtesy of Accuray.com)
7.

PETIGNAT P, JOLICOEUR M, ALOBAID A. (2006). Salvage
treatment with high-dose-rate brachytherapy for
isolated vaginal endometrial cancer recurrence.
Gynecol Oncol, 101, 445–449.

8.

CREUTZBERG CL, VAN PUTTEN WL, ET AL. (2001).
The morbidity of treatment for patients with
Stage I endometrial cancer: results from a
randomized trial.; PORTEC Study Group. The

Postoperative Radiation Therapy in Endometrial Carcinoma. Int J Radiat Oncol Biol Phys,
51(5):1246–55.
9.

OKEN MM, CREECH RH, ET AL. (1982). Toxicity
and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol,
5(6):649–55.

Bi-Rads Subcategorization as a Useful Predictor of Malignancy
In the late 1980s,
t he A merica n
College of
Radiology
( AC R ) b e g a n
a n initiative
to create the
Kerri Vincenti, MSI
Breast Imaging
Advisors: Laura Liberman,
Reporting a nd
MD, and Kimberly Feigin,
Dat a Sy stem
MD, Memorial Sloan(BI-RADS)
Kettering Cancer Center
lexicon for
mammography
interpretation in order to standardize
how to classify breast lesions and
quantify their likelihood of being
cancerous. Despite acceptance of this
lexicon, interobserver variability was
still high regarding the specific lesion
classifications.
In 2003, the ACR further clarified
each lesion by providing illustrations
and representative photographs of each
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example. In addition to introducing a
lexicon for sonography and MRI, the
latest BI-RADS also further organized
the category 4 lesions in three subgroups
— 4a, 4b, and 4c.1 Lazarus et al. and
Sanders et al. conducted retrospective
studies of these subcategories focusing
on microcalcif ications which both
showed that the subcategories were
useful predictors of malignancy.
One of the goals of this study was
to look at the positive predictive value
(PPV) of each subgroup to determine
whether there is statistically significant
correlation between the categories and
the occurrence of cancer for masses. This
HIPAA compliant and IRB approved
retrospective study reviewed reports of
73,760 mammograms at the New York
Memorial Sloan-Kettering facility from
Dec. 1, 2003–April 30, 2007 to identify
all lesions referred for biopsy (n=1575).
Patients were 23–95 years old at the

time of their diagnostic mammogram
(mean age 56.9 [± 13.3 years]). In all
cases, a core needle biopsy, stereotactic
core needle biopsy, or f ine needle
aspiration was performed to determine
pathology for the presence or absence
of malignancy. Synchronous suspicious
lesions (n = 261) were excluded to rule
out multiple findings with different
levels of suspicion. Film mammographic
examinations were performed at either
the Guttman Diagnostic Center or the
Breast Examination Center of Harlem.
Diagnostic evaluation included lateral
and magnification views for all patients
included in the study. Final assessment
categories were independently assigned
to each mammogram by one of five
interpreting radiologists as follows:
BI-RADS category 4a for lesions with
low likelihood of malignancy; category
4b for lesions with an intermediate
likelihood of malignancy; category 4c
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for lesions with moderate likelihood
of malignancy; and category 5 lesions
for highly suggestive of malignancy (>
95%).1 Statistical analysis was performed
using chi-square and Fisher’s exact tests.
Among 1,314 lesions, 382 (29%) were
assigned BI-RADS category 4 without
subcategorization, 451 (34%) 4a, 241
(18%) 4b, 88 (7%) 4c, and 152 (12%).5
Histopathology results were available for
1,233 lesions in 1,216 women (92.3%
follow-up). The cancer rate in these
1,233 lesions was 36% (441/1,233). The
cancer rate did not differ significantly
between lesions classified as BI-RADS
category 4 without subcategorization
(104/341 = 30%) vs. the sum of all
lesions classified as BI-RADS 4a, 4b,
and 4c (194/744 = 26%) (p = 0.2). As
expected, the cancer rate increased
significantly (p<0.001) with increasing
BI-RADS subcategory: the cancer rate
for subcategory 4a was 13% (58/433);
4b, 29% (64/223); 4c, 82% (72/88);

BI-RADS Category
4
4a
4b
4c
5
Total

Total Lesions
118
205
72
43
69
507

Cancerous Lesions
37
16
22
38
68
181

PPV
37/118 (31%)
16/205 (8%)
22/72 (31%)
38/43 (88%)
68/69 (99%)
181/507 (36%)

TABLE: Frequency of Cancer and PPV as a Function of BI-RADS Category. Bolded and unbolded PPV values were
found to be statistically significant with p-values<0.02 and p<0.001, respectively.

and 5, 97% (143/148). There was also
a statistically significant increase in the
cancer rate among masses (Table).
BI-R ADS 4 subcategories 4a/b/c
may be useful predictors of malignancy
for mass lesions. Further investigation,
including analysis of specific lesion
features, will assist radiologists in making
evidence-based recommendations for
use of BI-RADS subcategories 4a/b/c,
enhancing communication, practice,
and research.
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Occupational Radiation Exposure of Interventional Radiologists
and Staff During Performance of Biopsies Guided by CT Fluoroscopy
T he Nationa l
Council on
Radiation
Protection and
Measurements
reports that exposure to potentially
Sagine Berry-Tony, MSII
harmful ionizing
Advisor: Raymond
radiation from
Thornton, MD, Memorial
medica l proceSloan-Kettering Cancer
dures has seen a
Center
more than seven
fold increase
between the early 1980s and 2006.1,2
“The total number of CT examinations
performed annually in the US has risen
from approximately 3 million in 1980
to nearly 70 million in 2007 … greater
use of CT has resulted in a concurrent
increase in the medical exposure to ionizing radiation.”3 “During conventional
CT guided interventions, operation
of the CT scanner is performed at
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the operating console outside the CT
imaging room.”4 Images are captured
while all personnel step out of the
imaging room to the control area- a
protected location behind leaded glass,
thus greatly reducing if not eliminating
the risk of exposure to ionizing radiation.
During CT fluoroscopy however,
connection of a footswitch and control
panel directly to the gantry of the CT
scanner, require the physician operator
to stand in the CT suite while images
are acquired, imposing the risk of occupational radiation exposure.4 Personnel
who work in fluoroscopy suites routinely
wear leaded gowns to minimize their
occupational exposure to radiation.
Other dose mitigating strategies include
staying as far away as possible from the
X-ray source-inverse square law. Some
studies have shown substantial radiation exposure to operators who use CT
fluoroscopy. Our objective was to study

the amount of radiation reaching the
physician and nurse when they stand in
positions typical of daily work.
With an anthropomorphic operator
phantom positioned 80cm from the
gantry (Close), 160 cm from the gantry
(Far), and at the side of the CT unit
(Side), CT fluoroscopy was performed
at the patient phantom’s upper abdomen
using typical machine settings of 60 mA
and 120 kV. Radiation dose was recorded
at the operator’s: lens (with and without
leaded 0.75 mm lead equivalent eyeglasses), neck (with and without thyroid
shield), left chest wall (with and without
leaded apron), and left side (to simulate
extremity dose) using a solid-state dosimeter. Measurements were then repeated
with the operator phantom in the position typical of a nurse in a fluoroscopy

RADIATION EXPOSURE
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suite, approximately 350cm from the
gantry (Nurse). Measurements were
repeated with disposable tungsten-antimony drapes (0.25 mm lead equivalent)
on the patient phantom, and suspended
transparent leaded shields (0.5 mm lead
equivalent) positioned at the gantry, and
at 10 cm from the operator lens.
Results were expressed as the ratio
of scattered dose received by the operator phantom (µR) to the radiation
dose delivered to the patient phantom
(mGy cm). The shielding efficacy of each
strategy is expressed graphically.
Our findings show that operator dose
was minimized by stepping to the side of
the CT scanner when CT images were
being obtained. The profile of scattered
radiation from the CT scanner and the
shielding effect of the machine housing
are the best explanations for this observation. Nurse doses at 350 cm from the
midpoint of the gantry were similar to
maximally protected physician doses,
and likely due to the mechanism predicted by the inverse square law.
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Ratio Exposure to DLP (µR / mGy cm)
Locations
80 cm
160 cm
Eye Unprotected
22.15
6.81
Eye Protected (Glasses)
2.97
0.75
Eye Protected (Shield close to CT)
1.17
4.04
Eye Protected (Shield 10 cm from face)
0.40
0.00
Eye Unprotected (Rad Pad)
21.13
4.32
Eye Protected (Glasses and Rad Pad)
0.57
Neck Unprotected
9.66
5.44
Neck Protected
0.94
0.40
Neck Protected (Shield close to CT)
0.00
0.00
Neck Protected (Shield close to face)
0.00
Left Breast Protected (Apron)
0.69
0.00
Left Arm Unprotected
17.94
3.97
Left Arm Protected (Shield close to CT)
6.82
3.57
Left Arm Protected (Shield close to body)
0.33
Left Arm Unprotected (Rad Pad)
14.16
2.94

350 cm
1.30
0.00

Side
0.85
0.00

1.04

0.76

1.24
0.00

0.55
0.00

0.00
0.83

0.00
0.00

TABLE: CT Dose Index (CTDI): A characterization of absorbed dose, measured in a homogenous phantom by a

diagnostic medical physicist during quality assurance, quality control experiments; units are mGy.
Dose Length Product (DLP): An approximation of the total energy a patient absorbs from the scan; units are mGy cm.
microRoentgen (µR): A unit of radiation exposure, obtained by measuring the amount of radiation required to liberate
a certain amount of charge in a known volume of air.
2. EINSTEIN AJ. (2009). Medical imaging: the radiation issue. Nature Reviews Cardiology, 6(6),
436–438.
3. SMITH-BINDMAN R, LIPSON J, MARCUS R, KIM KP, MAHESH
M, GOULD R, MIGLIORETTI D, ET AL. (2009). Radiation
dose associated with common computed
tomography examinations and the associated
lifetime attributable risk of cancer. Archives of

Internal Medicine, 169(22), 2078–2086.
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High Levels of Intra-tumoral Tumor-infiltrating Lymphocytes and No
Angiolymphatic Invasion Increase Recurrence-free Survival in Stage 1A NSCLC.
The presence of
tumor infiltrating
lymphocytes
(TILs),
specifically
CD8 + cytotoxic
T-lymphocytes,
Zach Horne, MSII
have been found to
Advisor: Matthew
increase survival
Schuchert, MD, University
in many forms of
of Pittsburgh Medical
cancer, including
Center
NSCLC,
endometrial,
bile ductal, colonic, esophageal, and
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urothelial cancers, as well as melanoma
and follicular lymphoma.1–8
The relevance of TILs in the prognosis of NSCLC, however, still remains
controversial. In this study, we compared
the outcomes of stage 1A NSCLC with
and without tumor infiltrating lymphocytes to evaluate the effects of TILs on
recurrence and survival patterns.
From 2000 to 2009, 273 anatomic
segmentectomies and lobectomies were
performed on stage 1A NSCLC. Patients
were stratified into TIL - and TIL +
cohorts based on pathological evaluation.

Further investigation was conducted
on the effects of TILs in patients with
and without angiolymphatic invasion.
Variables analyzed include overall survival, recurrence-free survival, and type
of recurrence (locoregional vs. systemic).
Five-year recurrence-free survival
(RFS) was significantly increased in the
TIL+ group vs. the TIL - group (87%
vs. 73%, p = .011) [Figure 1], more so
in women (p = .016). The presence of
angiolymphatic invasion (ALI) was
associated with decreased five‑year RFS
versus patients without ALI (61% vs.
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85%, p<.001). Significantly, in the ALI
negative group, TIL+ patients experienced a significantly increased five-year
recurrence-free survival vs. TIL- patients
(93% vs. 80%, p = .036). Furthermore,
in TIL+ patients who did experience
recurrence, locoregional recurrences rates
were similar to those in the TIL- group,
at 3.5% and 5.4%, respectively. Systemic
recurrences, however, occurred in 16.4%
of the TIL- patients and only 6.4% of
the TIL+ patients (p = .0295). Results
are summarized in Table 1.
High levels of intratumoral TILs are
associated with improved recurrence-free
survival in stage 1A NSCLC patients as
well as a reduced likelihood of systemic
recurrence. When angiolymphatic invasion is not present, the beneficial effects
of TILs become even more profound.

REFERENCES:
1.

EEROLA AK, SOINI Y, PAAKKO P. (2000). A high
number of tumor-infiltrating lymphocytes are
associated with a small tumor size, low tumor
stage, and a favorable prognosis in operated
small cell lung carcinoma. Clin Cancer Res,
6:1875–81.

2.

KONDRATIEV S, SABO E, YAKIREVICH E, LAVIE O, RESNICK
MB. (2004). Intratumoral CD8+ T lymphocytes
as a prognostic factor of survival in endometrial
carcinoma. Clin Cancer Res, 10:4450–6.

3.

OSHIKIRIT, MIYAMOTOM, SHICHINOHET, ET AL. (2003).
Prognostic value of intratumoral CD8 + T
lymphocyte in extrahepatic bile duct carcinoma
as essential immune response. J Surg Oncol,
84:224-8.

4.

SCHUMACHER K, HAENSCHW, ROEFZAAD C, SCHLAG PM.
(2001). Prognostic significance of activated
CD8(+) T cell infiltrations within esophageal
carcinomas. Cancer Res, 61:3932–6.

5.

SHARMA P, SHENY, WEN S, ET AL. (2007). CD8 tumorinfiltrating lymphocytes are predictive of survival in muscle invasive urothelial carcinoma.
Proc Natl Acad Sci, 104:3967–72.

6.

STAIBANO S, MASCOLO M, TRANFA F, ET AL. (2006).
Tumor inf iltrating lymphocytes in uveal
melanoma: a link with clinical behavior? Int J
Immunopathol Pharmacol, 19:171–9.

7.

WAHLIN BE, SANDER B, CHRISTENSSON B, KIMBY E.
(2003). CD8+ T-cell content in diagnostic
lymph nodes measured by flow cytometry is a
predictor of survival in follicular lymphoma.
Clin Cancer Res, 13:388–97.

8.

NAITOY, SAITO K, SHIIBA K, ET AL. (1998). CD8+ T
cells infiltrated within cancer cell nests as a
prognostic factor in human colorectal cancer.
Cancer Res, 58:3491–4.

CLINICAL PRACTICE

FIGURE: Increased 5-year recurrence-free survival in TIL+ NSCLC.

			
TIL+
TILOverall Population
87%
73%
Gender			
		 Male
83%
76%
		 Female
90%
69%
Age, mean years (range)
68 (40-86)
68 (46-79)
Procedure			
		 Lobectomy
86%
74%
		 Segmentectomy
92%
72%
Histology			
		 Adenocarcinoma
85%
69%
		 Squamous Cell
90%
78%
		 Adenosquamous
—
—
		 Large Cell
—
—
		 Other
—
—
Differentiation			
		 Undifferentiated/Poor
92%
76%
		 Moderate
87%
63%
		 Well
—
—
Size			
		 <2cm
93%
73%
		 2-3cm
79%
73%
Angiolymphatic Invasion			
ALI+ 93%
79%
.126
		 ALI68%
56%
Recurrence Location (frequencies)			
		 Distant/Systemic
6.36%
16.42%
		 Locoregional
3.5%
5.4%

p
.011
.219
.016
—
.049
.133
.074
.147
.114
.355
.808
.341
.003
—
.004
.571

.036
.030
.555

TABLE: Five-year Recurrence Free Survival Characteristics
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Functional and Structural Connectivity of Language and Working Memory
in Children with Epilepsy
Epilepsy is one
of the most
common serious
neurological
conditions
affecting pediatric
populations.1
Meera Cheerharan, MSII
Seizure foci play
Advisor: Madison M.
a n impor t a nt
Berl, PhD, Children’s
role in terms
National Medical Center
of resulting
cognitive
impairments or changes that can occur
in these patients.2 Recent studies have
found that white matter tracts have
shown immature myelination patterns
in children with developmental and
cognitive delays.3 DTI has been used to
measure white matter tract integrity by
measuring directionality and degree of
water molecule movement in the brain.4
In epileptic patients with a localized
seizure focus, functions of the affected
hemisphere may latera lize to the
contralateral hemisphere. Subsequent
higher FA values (implying white
matter tracts with a greater degree
of myelination) are observed in the
contralateral hemisphere.5 Our crosssectional study compared 15 controls
to 16 pediatric epilepsy patients with
left hemisphere focal seizures. We
hypothesized that these patients would
have decreased FA values in the left
frontal lobe.
Scanned images were rated for
quality and FSL software was used;
images were pre-processed and the “most
representative” FA image was identified.
All subjects’ FA images were aligned to
this target image. TBSS was used to
generate a standard-space images for
all subjects and then merge these into
a single 4D image from which a mean
FA skeleton was constructed. Voxelwise
statistics were performed and using
the Johns Hopkins white matter atlas
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➤➤Retrolenticular internal capsule:
optic tract connections
➤➤Corona radiata (anterior, superior):
associated with reading ability
➤➤Posterior thalamic radiation:
connections between thalamus and
parietal, occipital lobes

FIGURE 1: Blue: patient FA > control FA

FIGURE 2: Blue: control FA > patient FA

T hese structures for which
patients have higher R side FA values
are implicated in reading, working
memory, etc., supporting the hypothesis
that patients with L sided lesions are
more likely to rely on R side white
matter to perform cognitive functions,
which become increasingly organized
throughout childhood. However, there
was no accompanying decrease in
the FA values of the corresponding
L side structures. Patients showed
bilateral increased FA in the genu of
corpus callosum and superior cerebellar
peduncles, as well as a bilateral increased
FA in the fornix — which has been
previously reported in other studies.6
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FIGURE 3: Blue: patient FA > control, in right
hemisphere

in FSL, our data showed increased FA
values for patients in the following R
hemisphere structures:
➤➤Anterior internal capsule: connections implicated in working
memory, learning, fine motor skills
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25-OH Vitamin D Levels in Patients withMeanRetinal
Pathology: A Retrospective Study
Serum 25–OH Vitamin D Levels Among Retinal Disease Groups
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Mean Serum 25–OH Vitamin D Levels
(ng/dl)

Vitamin D deficiency has now
been recognized
a s a pa ndemic
and low serum
levels have been
associated with
Atif Mohiuddin, MSII
a multitude of
Advisor: Jeevan R.
diverse adverse
Mathura, MD, GW Medical
health effects.1
Faculty Associates
In addition to its
well-established
role in calcium regulation, Vitamin
D also has antioxidant, immunomodulatory, anti-inflammatory, and
anti-angiogenic properties, 2,3 all of
which are mediated by the Vitamin
D receptor.4 Although the Vitamin D
receptor has been demonstrated to be
highly expressed in the human retina,5
the association between serum vitamin
D levels and retinal health has not been
established. In regard to retinal disease,
two studies have shown Vitamin D
serum levels to be inversely correlated
with diabetic retinopathy and a possible
protective role in age related macular
degeneration.6,7 However, the association between serum Vitamin D levels
and retinal occlusive diseases has not
been demonstrated.
Our retrospective study looked at
565 patients diagnosed with either diabetic retinopathy, age related macular
degeneration or retinal vascular occlusive disease over the past five years and
compared 25-OH vitamin D levels
drawn during the same time period.
These patients were subcategorized by
disease type and severity, and 25-OH
vitamin D levels were compared with an
age- and gender-matched control group
of patients seen in our ophthalmology
department without the aforementioned
diagnoses. In patients with multiple
levels taken, the earliest level was used
in an attempt to use levels taken before
Vitamin D supplementation therapy
was initiated. Exclusion criteria included
patients on 1000 IU or greater daily

25
20
15
10
5
0

Control

Retinal Vascular
Occlusive Disease

Diabetic
Retinopathy

Age-Related
Macular
Degeneration

Combined
Disease

Patient Categories

FIGURE: Mean Serum 25 — OH Vitamin D Levels Among Retinal Disease Groups.
dose Vitamin D. Results were compared
using student t-tests.
Our study showed that patients with
diabetic retinopathy (p<0.0001), retinal
vascular occlusive disease (p<0.035) and
the combined disease group (p<0.004)
had significantly lower serum 25-OH
vitamin D levels when compared to
patients without retinal pathology
(Figure). To the best of our knowledge, this is the first report comparing
Vitamin D levels and retinal vascular
occlusive disease. No statistically significant difference in serum 25-OH
vitamin D levels was observed in
patients with dry versus wet age related
macular degeneration (p<0.41) or
nonproliferating diabetic retinopathy
versus proliferating diabetic retinopathy
(p<0.66). There was also no significant
difference in levels of patients with
age related macular degeneration as a
whole compared to patients without
retinopathy. Further study is needed to
identify whether vitamin D can be used
as a marker for these conditions and if
supplementation has any role in altering
disease development or progress.
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Strengthening the Safety Net: Evaluating Access to Primary Care
in the Emergency Department
Uninsured and
low-income
p at ient s of ten
rely on the
“safety net” for
their medical care
which includes
local community
Anna Dill, MSII
health centers or
Advisor: Malika Fair,
MD, MPH, The George
low cost clinics,
Washington University
he a lt h depa r tSchool of Medicine and
ment services, and
Health Sciences
local emergency
departments
(ED).1 In Prince
George’s County the safety net system
is particularly limited because of a lack
of adequate primary care providers and
facilities to serve the counties’ 80,000
uninsured patients. 2 Many of these
patients resort to using the ED for routine medical care or conditions that are
preventable with consistent outpatient
primary care.3 Although patients can
receive treatment in the ED for any
health issue, the long term benefit of
care delivered in the ED is limited by the
lack of appropriate follow-up for patients
without a primary medical physician.4
This is particularly important in our low
income chronically ill population where
access to regular care could significantly
improve health status and reduce avoidable ED visits.
“Strengthening the Safety Net” was
proposed to determine if direct primary
care referral and appointment scheduling from the emergency department at
point of service would increase rates of
primary care follow up from the Prince
George’s County ED. Furthermore, the
study sought to assess the self described
perceived barriers to primary care in the
uninsured ED population.
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Acute
Chronic

Complaints With No Follow-up
Intervention Control
Total %
19
20
39 (88.64)
4
0
4 (9.09)

Intervention
7
4

Complaints With Follow-up
Control
Total %
p value
11
18 (66.67)
0.03
4
8 (29.63)
0.03

TABLE 1: Follow up results of patients with either chronic or acute medical conditions.
A randomized prospective pilot study
of ED adult patients was conducted. A
direct scheduler was placed in the ED
from 9 a.m to 5 p.m., Monday through
Friday to coordinate discharge follow
up for intervention patients. English
speaking patients without a primary
care physician who required follow up
with a PCP within a three-week time
frame were invited to participate. At
discharge, the intervention group had a
follow-up appointment made with either
of two participating low-cost clinics
and the control group was given the
routine discharge contact information
and instructions to schedule a followup appointment. All participants were
called one month after their ED visit
to ascertain if they followed-up and to
discuss barriers to follow-up. Clinics
were also called to verify appointment
attendance. A proportional t-test was
used for comparison of data.
Sixty-six patients were enrolled in
this study over a period of one month.
Demographic characteristics and disease
severity were similar between the intervention and control groups. Follow-up
rates were 29% for the intervention
group and 40% for the control group
(P = 0.25); there was no difference
in follow up between the two clinics
in the intervention group. The most
common reason for not following up
for both groups was a lack of transportation (13%), resolution of symptoms

(13 percent), and work conflict (13%).
Interestingly, patients with chronic
medical complaints were more likely
(30% vs. 9%, p = 0.03) to follow up
with an outpatient clinic. Overall results
indicated that while providing a scheduled appointment upon discharge from
the ED did not improve compliance
with outpatient follow up, patients with
chronic medical complaints were more
likely to obtain follow up.
The limitations of this study
included a small study population,
and differences in the services offered
between the two community clinics.
The implications of this study promote
further collaboration between emergency medicine and the community
health center network in Prince George’s
County, and there are currently policy
discussions at the administrative level
of the ED and the community clinics
to the benefits and drawbacks of the
results of this pilot study. Furthermore,
the study warrants further investigation
into efficacious program development
and implementation in targeting the
uninsured population that utilized the
ED for ambulatory primary care visits.
Subsidized transportation options and
flexibility of appointment hours may
contribute to higher compliance with
outpatient follow-up among this at risk
population. Also, the development of
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urgent care centers or services within
the community health network is a
perceived need, as many patients didn’t
follow up with a PCP due to absolving
symptoms at time of follow-up. It is
possible that there was higher follow
up rate in those patients with chronic
conditions because of the ongoing need
for affordable continuity of care.

Forgot Appointment
Lack of Transportation
Lack of Childcare
Lack of Eldercare
Work Conflict
Language Barrier
Symptoms Better
Inconvenient Hours
Cost
Location
Other
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Intervention %
2 (16.67)
4 (33.33)
0 (0.00)
1 (8.33)
4 (33.33)
1 (8.33)
3 (25.00)
—
—
—
0 (0.00)

Control %
1 (5.26)
0 (0.00)
0 (0.00)
0 (0.00)
0 (0.00)
1 (5.26)
1 (5.26)
2 (10.53)
1 (5.26)
2 (10.53)
5 (26.32)

Total %
3 (9.68)
4 (12.90)
0 (0.00)
1 (3.23)
4 (12.90)
2 (6.45)
4 (12.90)
2 (6.45)
1 (3.23)
2 (6.45)
5 (16.13)

TABLE 2: Reasons for lack of follow-up.
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Head Injury and Posttraumatic Stress Disorder Among Those Present South
of Chambers Street in Manhattan During the Sept. 11, 2001 Terrorist Attacks
Man-made disaster s le ave si gn i f ic a nt le vels
of stress on the
exposed population, and studies
have shown that
the mental health
Sarah Mohajeri, MSI
effects go beyond
Advisor: Steven D.
short-term stress
Stellman, PhD, Columbia
a nd a f fec t t he
University Mailman
popu l at ion on
School of Public Health,
multiple dimenWorld Trade Center
sions. The terHealth Registry
rorist attacks of
Sept. 11, 2001,
have been associated with a variety of
adverse health outcomes in the exposed
population such as asthma and other
respiratory conditions. The World Trade
Center Health Registry, a Bureau of the
New York City Department of Health
and Mental Hygiene, was created to
investigate the long-term health effects
of the Sept. 11 attacks and has conducted
multiple research projects following its
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inception. The baseline survey of 71,437
individuals exposed to the disaster,
conducted between 2003 and 2004,
reveals a prevalence of Posttraumatic
Stress Disorder (PTSD) of 15.5% among
lower Manhattan residents.4 PTSD has
been associated with multiple exposures
resulting from the attacks,3 with head
injuries being of special interest, as the
physical and cognitive consequences of
such an injury may be related to later
development of PTSD.

The relationship between PTSD and
head injury has been a subject of great
debate within the literature, both empirically and theoretically. Many studies
have reported associations between head
injury and PTSD, including a study of
Oklahoma City bombing survivors.8
Other studies have concluded PTSD
cannot develop following a Traumatic
Brain Injury (TBI),7 and some have even
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concluded that severe TBI is protective
against PTSD.5 None of these involved
World Trade Center survivors. To
examine this issue we investigated the
relationship between head injury and
PTSD outcome.
This study focused on a sub-sample
of registry enrollees who were physically present in the eligible area south
of Chambers Street in Manhattan,
between the time of the first plane
impact and noon (n=43,487) [The two
plane crashes occurred about a half-hour
apart.]. The baseline survey collected
information on head injury and several
measures of mental health, including
the PTSD Check-list (PCL) Civilian
Version.1,6 Exposure to head injury was
measured by asking respondents if they
experienced a concussion. Head injury
was one of seven specified categories of
physical injury.
Our study found that head injury
was a significant and strong predictor
of PTSD (Adjusted OR=5.2, 3.8-7.1)
within the population that was present
south of Chambers Street during the terrorist attacks. Based on previous research
on this population,3 we controlled for
the witnessing of horrific events, dust
cloud exposure, age, income, ethnicity,
and gender as possible confounding variables. Our findings were consistent with
literature that supports the association
between TBI and PTSD.
Findings from this study may help
future investigators to further examine
the relationship between head injury and
stress disorders, and to focus on possible
mechanistic processes that may be
responsible for the observed association.
The persistence of mental illness2 among
the population exposed to the terrorist
attack on Sept. 11 highlights the need
to provide treatment options and access
to medical resources to those who have
experienced traumatic events.
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Model 1
Model 2
Model 3
Model 4†
Model 5††
Crude OR
Crude OR
Adjusted OR
Adjusted OR
Adjusted OR
(95% CI)
(95%t CI)
(95% CI)
(95% CI)
(95% CI)
Head Injury 8.2 (6.3–10.8)
–
7.4 (5.6–9.7) 5.2 (3.8–7.1)
N/A*
Witnessing
–
3.0 (2.7–3.5) 3.0 (2.7–3.3) 2.3 (2.0–2.5)
2.3 (2.0–2.5)
Horrific Events
Dust Cloud
–
1.8 (1.7–2.0)
1.8 (1.7–2.0)
Age
0–17
1.0
1.0
		
18–24
1.8 (1.2–2.8)** 1.8 (1.2–2.8)**
		
25–44
3.7 (2.5–5.6)
3.7 (2.5–5.6)
		
45–64
4.4 (2.9–6.7)
4.4 (2.9–6.6)
		
65+
2.2 (1.4–3.4)*** 2.2 (1.4–3.4)***
Gender
Male
1.0
1.0
		
Female
1.4 (1.3–1.5)
1.4 (1.3–1.5)
Ethnicity
White
1.0
1.0
		
African American
1.5 (1.4–1.6)
1.5 (1.4–1.6)
		
Hispanic
2.2 (2.0–2.4)
2.2 (2.0–2.4)
		
Asian
1.0 (0.9–1.1)*
1.0 (0.9–1.1)*
		
Multiracial
1.8 (1.4–2.1)
1.8 (1.4–2.1)
		
Other
2.1(1.6–2.7)
2.1 (1.6–2.7)
Income
less than $25,000
4.8 (4.2–5.4)
4.8 (4.2–5.4)
		
$25,000–$75,000
2.3 (2.1–2.6)
2.3 (2.1–2.6)
		
$75,000–$150,000
1.4 (1.2–1.5)
1.4 (1.2–1.5)
		
$150,000 or more
1.0
1.0
Witnessing			
Horrific Events*			
N/A*
Head Injury
P<0.0001 except *(p>0.05), **p<0.01, ***p<0.001.
Model 1: univariate logistic model, head injury as single predictor variable, PTSD as outcome.
Model 2: univariate logistic model, witnessing horrific events as single predictor variable, PTSD as outcome.
Model 3: bivariate logistic model, head injury and witnessing horrific events as predictor variable, PTSD
as outcome.
† Hosmer and Lemeshow Goodness of Fit Test statistics: Chis-quare=16.1 DF=8 p<0.041.
†† Hosmer and Lemeshow Goodness of Fit Test statistics: Chis-quare=16.2 DF=8 p<0.040.
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Traditional Birth Attendants: A Non-Traditional Way to Improve Access to Prevention
of Mother-to-Child HIV Transmission Efforts among Women in Rural Southern India
Comprising
approximately
one-sixth of the
w o r l d ’s t o t a l
population, India
has faced a host
of medical and
socioeconomic
Jana Freeman, MSII
issues, including
Advisor: Purnima
access to maternal
Madhivanan, MBBS,
health care and
MPH, PhD, Public Health
a rising human
Research Institute,
immunodeMysore, India
f i c i e nc y v i r u s
(HIV) epidemic.
The prevalence of HIV/AIDS among
the total adult population is 0.36%,
with an estimated 2.5 million people
currently living with HIV/AIDS.1 In the
State of Karnataka in Southern India,
the primary mode of HIV transmission is heterosexual contact, and HIV
prevalence is estimated to be 0.69%
among the general population. Notably,
HIV prevalence at antenatal care (ANC)
clinics in Karnataka State has exceeded
1% in recent years.2
A particular challenge to the HIV
epidemic in India has been access
to maternal care for HIV-infected
women of reproductive age. In many
rural areas of Karnataka State, less
than 10% of all HIV-infected women
receive ANC services, including access
to antiretroviral medication during
pregnancy and delivery to decrease the
risk of mother-to-child transmission
of HIV. Traditional birth attendants
(TBA) attend many home deliveries in
these rural communities, yet TBA do
not receive training for prevention of
mother-to-child transmission of HIV
(PMTCT).
In this study, we examined the prevalence of TBA-assisted births and the provision of ANC in a large village-based
population sample in the subdistrict of
Mysore, India. Using enumerated data
on village households, we conducted a

PUBLIC HEALTH

Interview with a traditional birth attendant (TBA) in a rural village of Mysore, India. Public Health Research Institute.

population based door-to-door survey
of a random sample of rural villages
from August to September 2008.
Sociodemographic data were collected
from each household, including the
mother’s age at first childbirth, number
of children below six years of age in
the household, place of delivery, who
assisted each delivery, and whether antenatal care was received. Multivariable
logistic regression was used to assess
factors associated with receiving ANC.
The study was conducted by Public
Health Research Institute (PHRI) in
Mysore, India and received funding
from the Elizabeth Glaser Pediatric
AIDS Foundation.
Among 16 villages, we surveyed
1,342 households (94.4% response
rate). The median age of women at first
delivery was 19.5 years (range 11–46
years). Among all children under six
years of age, 39.3% were delivered at
home versus 60.7% in a hospital/clinic.
Deliveries were assisted by a doctor or
nurse (62.7%), TBA (31.1%), relative
(5.8%), and other (0.4%). In multivariable analysis, factors independently
associated with receiving ANC included
institutional delivery (odds ratio [OR]
13.0, 95% confidence interval [CI]:

8.4–20.1) and high socioeconomic status
(OR 2.7, 95% CI: 1.8–3.9).
Our data showed that a substantial
proportion of women delivering at home
were less likely to receive antenatal care
and HIV prevention services. As we
continue to confront the HIV epidemic
in India with a multipronged and openminded approach, particularly in rural
areas, TBA performing home deliveries
might serve as key community members
to increase access to ANC services for
women who do not receive care in hospitals. Identifying and training TBA in
HIV prevention strategies might allow
for an alternative means to improve
access to health care in these hard-toreach populations.
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A Sociocultural Evaluation of Neglected Tropical Diseases (NTDs)
and Deworming Campaign Efforts in Northern Rwanda
Neglected tropical diseases
(NTDs) represent one of the
greatest economic
and health burdens experienced
Lindsay Wheeler, MSII
by the people of
Advisor: Peter Hotez, MD,
Rw a nd a . Dat a
PhD, FAAP, The George
from 2008 found
Washington University
t hat 66% of
School of Medicine and
the school-aged
Health Sciences
population was
in fec ted w it h
soil-transmitted helminthes (STHs),
including ascariasis, trichuriasis, and
hookworm. In some districts in the
Northern Province, the prevalence
among school children surpassed 90%.1
Parasitic infections are reported by
health centers to be the second most
frequent reason for outpatient visits.2
With support from Legatum, an
international investment group, and in
collaboration with the Global Network
for Neglected Tropical Diseases, the
Access Project and Ministry of Health
joined forces to develop an integrated
NTD education and treatment campaign to lower the burden of STHs
and schistosomiasis. The purpose of
this community-based research was to
evaluate community perceptions of the
current control efforts as well as knowledge of STHs and schistosomiasis.
We conducted 122 interviews in
the districts of Musanze and Burera,
two regions of northern Rwanda that
received recent mass drug administration (MDA) against STHs and schistosomiasis. The interviews consisted
predominantly of open-ended questions
and specific multiple-choice questions.
The total sample size included 60 children and 62 adult volunteers, including
community health workers, health
center staff, teachers and parents.
Results indicated that both children
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Working with a translator to interview the mother of a child at risk for soil transmitted helminths in the Bureau District
of northern Rwanda.

and adults regard infection with STHs
and schistosomiasis as a significant issue.
Over 75% of health center staff and
community health workers identified
intestinal worms as their first or second
priority medical concern, compared to
HIV/AIDS, tuberculosis, malaria and
pneumonia. Adults identified several
consequences of worms, including
delayed physical development, promotion of poverty and absence from school.
Poverty was cited as the most common
barrier to prevention. Additionally, community health workers reported many
people not following advice on NTD
prevention because it was impractical or
not considered important. These results
suggest that strengthening the message
of behavior change and reinforcing the
deleterious effects of worm infections is
critical to the future of the campaign.
Larger issues, such as access to clean
water and resources must be confronted
in order to achieve a long-term impact
in NTD control.
Nearly all the children interviewed
believed they had been infected and
treated. They understood the causes of
infection and symptoms, which they had
learned primarily through school. The

vast majority of the children were “very
worried” about infection and reported
that they were practicing the recommended behaviors to prevent infection.
Most (73%) reported hand washing
before eating, but far fewer (45%)
reported hand washing after using the
toilet, indicating a need for a targeted
education campaign.
Overall, our data suggest that among
a sample of adults and children in
Northern Rwanda there is a basic
knowledge of the risks of NTDs and
that current control efforts are accepted.
Although this study has several limitations, including reporting bias and small
sample size, we believe it highlights the
major attitudes expressed by the community. Further research is needed to
better understand the direct impact of
NTDs on school attendance, economy,
and child health and development in
Rwanda.
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